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Abstract  
Mitochondria are key organelles mainly devoted to energy production through ATP synthesis. Such a 
function is permitted by oxidative phosphorylation (OXPHOS) within mitochondria inner membrane. 
Key components of the OXPHOS processes are encoded by mitochondrial DNA (mtDNA) that is 
particularly sensitive to exogenous or endogenous insults. As a result, mtDNA mutations are often 
correlated with OXPHOS dysfunction leading to diseases. ROS production in mitochondria is the 
main source of mtDNA damage. Such DNA damages are mainly taken over by BER systems within 
mitochondria. In this study, we focused on this peculiar mitochondrial DNA repair system in 
Drosophila. In a first step, we analysed in a comprehensive manner through microarray, most 
glycosylases and endonucleases involved in mitochondrial BER and compared their evolution during 
aging. Using mutant flies for specific BER enzymes, we started to decipher some of the transcriptional 
interactions between key BER actors. In a second step, Parp molecule was further studied due its 
changes in all mutant contexts and for its importance in several cellular processes. We described its 
nuclear but also its mitochondrial location in S2 cells. Interestingly, two Parp mRNA variants were 
observed showing distinct regulations following stress induction.  However, PARP protein isoforms 
observed in this study were different compared to what was described in literature. This discrepancy is 
discussed. 
Key words: Mitochondrial DNA, DNA repair, BER, microarrays, Poly(ADP-ribosyl)ation, PARP, 
PARG 
Résumé 
Les mitochondries sont des organites essentiels pour la production d'énergie cellulaire grâce à la 
synthèse d'ATP au cours des étapes de phosphorylations oxydatives (OXPHOS). Les complexes de la 
chaine respiratoire sont en partie codés par le génome mitochondrial (ADNmt), dont la structure est 
très sensible aux facteurs exogènes ou endogènes De nombreuses mutations de l'ADNmt sont associés 
à des dysfonctionnements de la chaine respiratoire conduisant à des pathologies. La production 
d’Espèces Oxygénées Réactives (EOR) mitochondriale est la principale source de dommages à 
l’ADNmt. Une voie de réparation particulière, le système de réparation par excision de bases (BER) 
est mis en œuvre dans ce cas. Nous avons, au cours de notre étude, analysé le système BER 
mitochondrial chez la drosophile. Dans une première approche, nous avons caractérisé de manière 
globale par une technologie de puces à ADN un ensemble de glycosylases et endonucléases 
impliquées dans la voie BER mitochondriale et comparé leur variation au cours du vieillissement. 
Cette étude a été complétée par une analyse transcriptionnelle sur des modèles de drosophiles 
mutantes pour des enzymes spécifiques de la voie BER, ceci afin de déterminer les éventuelles 
interactions transcriptionnelles entre les acteurs de cette voie. L’ARNm de Parp présentait de fortes 
variations dans les différents contextes mutants testés. C’est une molécule essentielle de la réparation 
BER. Elle a fait l’objet dans un deuxième temps, d’une étude plus approfondie. Dans le modèle des 
cellules S2, PARP bien que majoritairement nucléaire est également présent dans la mitochondrie. Le 
comportement différentiel des deux variants ARNm de Parp a pu être mis en évidence lors de stress 
cellulaires. Les isoformes protéiques de PARP observées dans nos études apparaissent différentes de 
celles habituellement décrites dans la littérature. Cet aspect a été discuté. 
 
Mots-clés : ADN mitochondrial, Réparation, BER, puces ADN, Poly(ADP-ribosyl)ation,  PARP, 
PARG 
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INTRODUCTION 
I.ЍMitochondria 
      According to the endosymbiosis theory, mitochondria origin is from -proteobacteria, 
which after the internalization by an anaerobic cell, (Figure 1), carried out an endosymbiotic 
relationship with them, based in exchanges of metabolites, energetic sources such as ATP and 
complex mechanism of signaling (Kutschera U et Niklas KJ., 2005). 
Figure 1: Endosymbiosis theory:  The first eukaryote may have originated from an ancestral prokaryote that 
had undergone membrane proliferation, compartmentalization of cellular function (into a nucleus, lysosomes, 
and an endoplasmic reticulum), and the establishment of endosymbiotic relationships with an aerobic 
prokaryote, and, in some cases, a photosynthetic prokaryote, to form mitochondria and chloroplasts, 
respectively. (modified from http://mrkingbiochemistry.files.wordpress.com/2013/02/theory-of-
endosymbiosis.gif?w=300&h=166 ) 
 
     In mammalian the number of mitochondria per cell differs widely from cell type to cell 
type. Robin et al. calculated the virtual mitochondrial number/cell range. They estimated 
the virtual number of mitochondria per cell measuring a plasmid probe developed that 
represent DNA/mitochondrion. They propose a range from 83 ± 17 mitochondria per cell 
(Robin ED, et R Wong., 1988).  
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I.1. Structure  
I.1.1. Main features 
     Mitochondria contain two membranes (outer and inner) composed of phospholipid bilayers 
and proteins. The two membranes have different properties and they delimit three 
compartments such as: cytosol, intermembrane space and mitochondrial matrix.  
The structure of mitochondria is represented in Figure 2 and shows: 
a) outer membrane  
b) inner membrane  
c) cristae  
d) intermembrane space (zone between outer and inner membrane)  
e) mitochondrial matrix  
 
 
Figure 2: Electron microscopy of mitochondrial structure (modified from  Herrmann JM. et Riemer J., 2010). 
I.1.2. The inner compartments 
     I.1.2.1. The intermembrane space 
     The intermembrane space is the space between the outer and the inner membrane. Its 
nature is very similar to cytoplasm; it became clear very recently that the intermembrane 
space plays a pivotal role in the coordination of mitochondrial activities with other cellular 
processes. In human, these activities include the exchange of proteins, lipids, or metal ions 
between the matrix and the cytosol, the regulated initiation of apoptotic cascades, signalling 
  16 
pathways that regulate respiration and metabolic functions, the prevention of reactive oxygen 
species produced by the respiratory chain, or the control of mitochondrial morphogenesis1.  
 
     In Yeast mitochondria, several proteins were localized in the intermembrane space such as: 
Ups1p, Ups2p, Cytochrome bz and Cytochrome c (Cyt c) and peroxidase (Maccecchini ML., 
1981 ; Tamura Y et al., 2012). 
 In normal functioning of mitochondria, Cyt c remains attached (electrostatic interactions) 
with proteins (complex II and IV) inserted in inner mitochondrial membrane. A disorder in 
electrostatic potential of inner membrane leads to the traffic of Cyt c to cytosol where it is 
involved in apoptosis pathway (Liu X. et al., 1996). 
     I.1.2.2. The mitochondrial matrix 
     The mitochondrial matrix is the scenario of metabolic pathways implicated in ATP 
production, such as: fatty acid oxidation, amino acid catabolism and Krebs cycle (also named 
the citric acid cycle CAC). (Figure 3) The machinery enzymes of the CAC is represented in 
different sub-compartments (metabolic canalization) in the mitochondrial matrix, with the 
exception of succinate dehydrogenase, which is bound to the inner mitochondrial membrane 
as part of Complex II.  
 
     The mitochondrial matrix can integrate cytosolic and mitochondrial pathways where 
metabolites such as, amino acids, fatty acid and glucose become in ATP. Recently, thanks to 
microscopy and mass spectrometry techniques, 495 proteins inside the 
human mitochondrial matrix were identified. The method was based on a genetically 
targetable peroxidase enzyme that biotinylated nearby proteins, which were subsequently 
purified and identified by mass spectrometry. Also it was identified 31 proteins not previously 
involved in mitochondria (Rhee HW. et al., 2013). 
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Figure 3: Schematic representations of acetyl-CoA integration to CAC (left) and the different reaction of CAC 
implicating acetyl-CoA integration (right) http://oregonstate.edu/instruction/bi314/summer09/Fig-11-02-0.jpg 
and http://content.answcdn.com/main/content/img/oxford/Oxford_Chemistry/0192801015.krebs-cycle.1.jpg (left) 
 
I.1.3. The Outer mitochondrial Membrane  
     The mitochondrial outer membrane (OMM) separates the intermembrane space from the 
cytosol, which encloses totally the organelle. OMM lipid composition is near 40% of 
phospholipids permitting the whole exchange of metabolites between mitochondrial internal 
compartments and the cytosol in eukaryote cell. OMM creates a diffusion barrier for small 
molecules such as adenine nucleotides, creatine phosphate and creatine, causing rate-
dependent concentration gradients as a prerequisite for the action of ADP shuttles via creatine 
kinases or adenylate kinases. If the OMM becomes leaky, Cyt c and apoptosis-inducing factor 
can be released (Gellerich FN. et al., 2000 ;  Horvath SE. et Daum G., 2013). 
     The protein voltage-dependent anion-selective channel (VDAC) (Rostovtseva TK., 2012) 
constitutes the main pathway for ATP, ADP, and other mitochondrial metabolic substrates in 
OMM. Recent findings suggest that regulation of VDAC by cytosolic proteins, such as 
kinases, and cytoskeletal proteins, dynamically and globally controls mitochondrial 
metabolism in normal cells and might play a role in aerobic glycolysis in cancer cells (the 
Warburg effect). Bigger molecules can only cross the OMM by active transport through 
mitochondrial membrane transport proteins, and mitochondrial pre-proteins are imported 
through specialized translocase complexes (Figure 4) as translocase outer membrane (TOM). 
The OMM also contains enzymes involved in: fatty acids elongation, hormones oxidation and 
tryptophan catabolism.  
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Figure 4: The pre-protein import machinery of mitochondria. Abbreviations: MIA, mitochondrial 
intermembrane space import and assembly; SAM, sorting and assembly machinery; TIM, translocase of inner 
membrane; TOM, translocase of outer membrane (Bohnert M, et al., 2007).  
I.1.4. The Inner mitochondrial Membrane  
     The Inner mitochondrial Membrane (IMM) is composed about 80 % protein and only 20% 
of phospholipids.  
 
a) According to phospholipid composition: Mitochondria are capable of synthesizing 
several lipids autonomously such as phosphatidylglycerol, cardiolipin and in part 
phosphatidylethanolamine, phosphatidic acid and CDP-diacylglycerol.  
b) According to proteins composition, the IMM doesn't contain porins, the metabolic 
traffic is due to: protein import machinery and specific protein transportation, such as:  
TIM22 and TIM23. The oxidative phosphorylation (OXPHOS) carried out in IMM 
involved the complexes of electron transport and ATP synthetase (Dimroth P, Kaim 
G, et Matthey U., 2000 ; Hunte C et al., 1993). 
      In Eukaryotes, the IMM presents different receptors involved in diverse pathways such as: 
Ca2+ internalization (Hajnóczky G et al., 2002) or in mtDNA maintenance (Rossi MN et al., 
2009). 
Other mitochondrial membrane lipids such as phosphatidylcholine, phosphatidylserine, 
phosphatidylinositol, sterols and sphingolipids have to be imported (Becker T, et al., 2013). 
The more important phospholipid from IMM is the cardiolipin (CL), which provides essential 
structural (Figure 5) and functional support to several proteins involved in mitochondrial 
bioenergetics. Thus, CL leads to IMM freely permeable only to oxygen, carbon dioxide, and 
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water, but slightly permeable to the passage of ions and molecules across the membrane 
without carriers. CL mediates the cooperativity between cytochrome-c-binding sites in the 
dimeric enzyme complex (Arnold S. et Kadenbach B., 1997). 
  A)   B)  
Figure 5: (A) 3D conformation of CL  http://classconnection.s3.amazonaws.com/737/flashcards/1944737/jpg/cardiolipin1349112348119.jpg;  
and (B) formula IUPAC: http://www.chemgapedia.de/vsengine/media/width/433/height/128/vsc/de/ch/16/im/divpic/cardiolipin.svg.jpg  
 
 
 
Figure 6: Schematic representation of ATP synthesis. Three H+ pumping sites create variation in the inner 
membrane potential (modified from http://ccforum.com/content/figures/cc6779-2-l.jpg) 
 
I.1.5. Mitochondrial DNA 
     In humans, the mitochondrial genome (circular double-stranded DNA) is about 1% of 
genomic DNA and it is composed of 16 569 base pairs (Figure 7). This DNA is devoid of 
introns and histones (Anderson S. et al., 1981). 
     I.1.5.1. Organization 
     According to Figure 7, the mtDNA contains 37 genes (Adams KL, Palmer JD., 2003), 
which represent the 95% of total mitochondrial genome, coding for: 22 transfer RNA, 2 
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ribosomal RNA genes (in yellow) (Montoya J et al., 1982 ; Christianson TW et Clayton 
DA., 1986 ; Montoya J, Gaines GL, et Attardi G., 1983) and 13 polypeptides: 7 subunits - 
ND1, ND2, ND3, ND4, ND4L, ND5, and ND6 (all in green) - of Complex I (NADH-
Coenzyme Q oxidoreductase); 1 subunit - cytochrome b (in red) - of Complex III (CoQ-cyt c 
oxidoreductase), 3 subunits - COX I, COX II, and COX III(all in blue) - of Complex IV (cyt c 
oxidase, or COX), and 2 subunits - ATPase 6 and ATPase 8 (both in gray) - of Complex V 
(ATP synthase) (Popot JL. et C de Vitry., 1990). 
 
 
 
Figure 7: Schematic representation of the human mtDNA (Wanrooij S et Falkenberg M., 2010). 
     The genes organization is strongly conserved in every completely sequenced mitochondrial 
genome. The remaining 5% of mitochondrial genome is a non-coding region named D-loop 
(or zone A-T rich) (in white). The D-loop presents an origin of DNA synthesis in each strand 
named OL the origin of light (lagging) strand synthesis and OH the origin of heavy strand. 
 
     I.1.5.2. mtDNA replication 
 
     The Figure 8 shows different replication modes of mammalian mtDNA.  
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Figure 8: Schematic representations mtDNA replication modes. (A) Strand-displacement replication mode. (B) 
RITOLS (left pathway) and strand coupled (right pathway) mode of mtDNA replication (Antoshechkin I,  et al., 
1997). 
     Replication of leading strand (H-strand) initiates at OH and proceeds unidirectionally 
(black arrow), displaying the parental H-strand as ssDNA. When OL (or OLalt) is exposed, 
the lagging strand (L-strand) synthesis initiates in the opposite direction (gray arrow).  
 
     In the ribonucleotide incorporation throughout the lagging strand (RITOLS) model, 
replication of leading strand (H-strand) initiates at a discrete origin (OR) and proceeds 
unidirectionally (black arrow), displaying the parental H-strand. The lagging strand (L-strand) 
is initially laid down as RNA (red line) using the displayed H-strand as template. The RNA is 
subsequently replaced by DNA (gray arrow), which probably starts as soon as OL is exposed 
by a yet unclear mechanism. In the strand-coupled mode (right pathway) initiation of both 
leading- (H-strand) and lagging strand (L-strand) synthesis occurs bidirectionally from 
multiple origins across a broad zone downstream of OH. This is followed by progression of 
both forks until the forks arrest at OH (Antoshechkin I, et al., 1997). 
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     I.1.5.3. mtDNA transcription  
     In human cells, each strand contains promoter for transcriptional initiation, one on the 
light-strand promoter (LSP) and two on the heavy-strand promoter (HSP), (Figure 7). 
Transcription from the mitochondrial promoters produces polycistronic precursor RNA 
encompassing all the genetic information encoded in each of the specific strands, and the 
primary transcripts are processed to produce the individual tRNA and mRNA molecules 
(Clayton DA., 1991). T he transcription of mtDNA operates in each promoter independently 
and it is carrying out oriented in opposite direction. The heavy strand has two sites of 
transcription initiation such as HSP1 and HSP2 Besides, the strand-coupled and the RITOLS 
models coexisting as interconnected events leading as multiple priming sites of the new 
lagging strand for the DNA synthesis.  
     More recently, Reyes and collaborators observed that long tracts of RNA are associated 
with replicating molecules of mtDNA and they suggested that the mitochondrial genome of 
mammals is copied by a non classical mechanism (synthesis in parallel of each strand with 5’-
3’ orientation)  
     Finally using DNA synthesis in organelle, they demonstrated that isolated mitochondria 
incorporate radiolabeled RNA precursors, as well as DNA precursors, into replicating DNA 
molecules. They indicate that RITOLS is a physiological mechanism of mtDNA replication, 
and that it involves a 'bootlace' mechanism, illustrated in (Figure 9) in which processed 
transcripts are successively hybridized to the lagging-strand template, as the replication fork 
advances (Reyes A et al., 2013). 
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Figure 9: The bootlace model of mtDNA replication. Preformed (L-strand) transcripts, including 
complementary tRNA and mRNA hybridize to the template lagging strand of mammalian mtDNA as leading 
strand DNA synthesis proceeds. RNA recruitment is an ongoing process 
 
     The transcription machinery in budding yeast appears less complicated, since it only 
contains one single TFB1M/TFB2M homologue, which is denoted mt-TFB or Mtf1. The S. 
cerevisiae mitochondrial RNA polymerase (Rpo41) and mt-TFB form a heterodimer that 
recognizes mitochondrial promoters and initiate transcription (Cliften PF. et al., 1997 ; 
Mangus DA, et al., 1994). TFAM (from human mitochondria) and its homologue from yeast, 
Abf2, are not required for transcription of mtDNA (Diffley JF et Stillman B., 1991 ;  Parisi 
MA, et al., 1993 ;  Dairaghi DJ, et al., 1995) but rather have a role in mtDNA maintenance 
and packaging. Recently, by overexpressing human TFAM in P1 artificial chromosome 
(PAC) transgenic mice, it was reported that also mammalian TFAM may serve as a key 
regulator of mtDNA copy number. This results that the human TFAM protein is a poor 
activator of mouse mtDNA transcription, despites its high capacity for unspecific DNA 
binding (Campbell CT, et al., 2012). Now, therefore it would be possible to dissociate the 
role of TFAM in mtDNA copy number regulation from mtDNA expression and mitochondrial 
biogenesis in mammals in vivo. 
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     The yeast POLRMT contains a unique amino-terminal extension, which is absent in 
homologous bacteriophage RNA polymerases. The function of the amino-terminal extension 
is separable from the known RNA polymerization activity of the enzyme (Wang Y et Shadel 
GS., 1999) 
     In support of this notion, the domain interacts specifically with Nam1, a protein originally 
identified as a high copy suppressor of mtDNA point mutations that affect splicing of introns 
in budding yeast. The N-terminal domain may therefore provide the means to couple factors 
involved in additional aspects of RNA metabolism directly to the transcription machinery 
(Rodeheffer MS. et al., 2001). 
     According with S. cerevisiae transcription model, it will be of interest to analyze human 
mitochondrial transcription. It was demonstrated in human that the levels of TFAM directly 
regulate the activity of both TFB1M/POLRMT - and TFB2M/POLRMT -dependent mtDNA 
transcription both in vivo and in vitro (Falkenberg M.et al., 2002). 
      The TFAM protein contains two tandem HMG box domains separated by a 27-amino-acid 
residue linker region and followed by a 25-residue carboxy-terminal tail. Mutational analysis 
of TFAM has revealed that the tail region is important for specific DNA recognition and 
essential for transcriptional activation (Shadel GS, et Clayton., 1995).  
     TFAM can bind, unwind and bend DNA without sequence specificity, similar to other 
proteins of the HMG domain family (Fisher RP. et al., 1992).  
     The sequence-specific binding of a TFAM tetramer (Antoshechkin I, et al., 1997), 
upstream of HSP and LSP, may allow the protein to introduce these structural alterations at a 
precise position in the promoter region and perhaps partially unwind the start site for 
transcription.  
     This model may explain why the exact distance between the TFAM binding site and the 
start site for LSP transcription is of critical importance  (Dairaghi DJ, et al., 1995). 
     The POLRMT (with proof-reading ability) can collaborate with Twinkle protein (with 5’  
to 3’  DNA helicase) in DNA replication (McKinney EA, Oliveira MT 2013).  
     Also, the Figure 10 shows POL , POLand POLRMT action
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Figure 10:  Proteins at the human mtDNA replication for (Wanrooij S et Falkenberg M., 2010). 
 
     The mtDNA replication machinery exposes OL in its single-stranded conformation. Strand 
displacement causes the origin sequence to adopt a stem–loop structure, which is recognized 
by an origin-specific primase (Wong TW et Clayton DA., 1985 A ; Wong TW et Clayton 
DA., 1985 B ; Wong TW et Clayton DA., 1986).  
          I.1.5.3.1. Mitochondrial RNA polymerase (POLRMT)  
     The POLRMT was initially identified in Saccharomyces cerevisiae. This enzyme is a 
unique mitochondrial RNA polymerase that is distinct from the nuclear RNA polymerases 
(Greenleaf AL, et al., 1986 ;  Kelly JL, et al., 1986). 
     In human cells POLRMT was later identified and sequence analysis demonstrated that it 
was structurally related to the bacteriophage T7 RNA polymerase (Tiranti V, et al., 1997). 
The POLRMT as the T7 homologue cannot initiate transcription on its own (Fuchs E, et al., 
1971), but requires the simultaneous presence of a high mobility group-box protein 
(mitochondrial transcription factor A; TFAM), and either transcription factor B1 (TFB1M) or 
B2 (TFB2M) (Fernández-Silva P., 2003).  
     Both TFB1M and TFB2M can form a heterodimeric complex with POLRMT. The four 
proteins of the basal mitochondrial transcription machinery have been purified in recombinant 
form and used to reconstitute transcription in vitro with a promoter-containing DNA fragment 
(Falkenberg M, et al., 2002).  
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     The POLRMT is not only required for transcription, besides, at the origin of heavy strand 
DNA replication (OH), it generates the RNA primers used to initiate leading-strand mtDNA 
synthesis (Wanrooij S. et al.,  2008 ;  Chang DD et Clayton DA., 1985 ; Chang DD, 
Hauswirth WW, et Clayton DA., 1985). About 100 nucleotides are primed in LSP region 
leading strand DNA synthesis (Figure 11). 
 
 
Figure 11: Schematic representation of the D-loop regulatory region. The three conserved sequence blocks 
(CSBI, CSBII and CSBIII) are located just downstream of light-strand promoter (LSP). Transition from RNA 
primer to the newly synthesized DNA has been mapped to sequence within or near CSB II (Kang D et al., 1997). 
The conserved termination-associated sequence ( Pham XH.  et al., 2006) (TAS) elements are located at the 3' of 
the nascent D-loop strand and are proposed to be a major regulation point of mtDNA replication. 
Abbreviations: HSP, heavy-strand promoter; LSP, light-strand promoter; OH, origin of H-strand; F, tRNA 
phenylalanine; P, tRNA prolin (Wanrooij S. et al., 2008).  
 
     The Figure 12 shows in three steps the different proteins involved in mtDNA 
transcription. The POLRMT has the capacity to specifically initiate RNA primer synthesis at 
the OL stem–loop structure. At this point, POL replaces POLRMT and lagging strand DNA 
synthesis is initiated. Interestingly, unlike in H-strand replication, the primer hand-off 
between POLRMT and POL could be reconstituted in vitro, suggesting that this event in OL 
dependent initiation is not a regulated event (Wanrooij S. et al., 2008). 
 
     The proposed model is mainly based on in vitro data, but receives support from two-
dimensional gel electrophoresis (2D-PAGE) analysis in combination with siRNA knockdown 
of POLRMT. In human cells, depletion of POLRMT generates replication intermediates with 
delayed lagging strand synthesis, thereby providing evidence for POLRMT acting as a 
lagging-strand primase also in vivo (Fusté JM. et al., 2010). 
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Figure 12:  Schematic model of DNA strands synthesized: (A) the leading strand (H-strand) DNA replication 
machinery approaches the OL sequence (yellow). (B) the upon passage, single-stranded OL is exposed and 
adopts a stem–loop structure. MtSSB is unable to bind to the stem–loop and POLRMT can initiate primers from 
the poly-dT stretch in the single-stranded region of OL (C). After about 25 nucleotides (dotted red), POLRMT is 
replaced by POLγ, and lagging-strand DNA (L-strand) synthesis(Fusté JM. et al., 2010). 
 
          I.1.5.3.2. Transcription regulation in human mitochondria 
     Transcription of mitochondrial genes is carried out by POLRMT, together with several 
nuclear-encoded transcription factors. Mitochondrial transcription (and as a consequence 
oxidative phosphorylation) may be regulated by transcription initiation and termination 
factors, and by changes in ATP levels in response to alterations of the cell metabolic demands 
(Sologub MIu, et al., 2009). 
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     Recently, it has been suggested that transcription in mitochondria is also coordinated with 
other crucial processes such as DNA replication and translation, indicating the importance of 
studies of molecular mechanisms of mitochondrial gene expression in these organelles 
(Sologub MIu, et al., 2009).  
     It was reported different levels among the steady-state of the promoter-proximal transcripts 
and steady-state of promoter-distal from mRNA transcripts (Gelfand R et Attardi G., 1981).  
     The second heavy-strand promoter dedicated to rRNA gene transcription justifies this 
difference in transcript levels (Montoya et al., 1982 ;  Montoya., 1983).  
     Besides, the existence of a tridecamer template sequence downstream of the 16S rRNA 
3′-end, which serves as a binding site for the mitochondrial transcription termination factor 
mTERF (Christianson TW et Clayton DA., 1988 ; Kruse B, et al., 1989 ; Fernandez-Silva 
P. et al., 1997).  
     Although mTERF binding to the termination sequence blocks transcription bidirectionally 
in a partially purified human mitochondrial system, it only blocks heterologous RNA 
polymerases in the direction opposite that of mitochondrial rRNA synthesis (Shang J. et 
Clayton DA., 1994).  
     The number of mitochondrial proteins is estimated 10 % of the total cellular proteome. But 
only a few polypeptides of OXPHOS are translated in mitochondria (due to mtDNA coding 
limitation).  
     Certainly, the mitochondrial translation system is very similar to the bacterial system. It is 
inhibited by chloramphenicol and initiation is carried out by a formyl-methionine. Another 
feature of this system is the use of a genetic code that differs from the universal genetic code 
for several codons (Osawa S et al., 1992).  
     The Table 1 shows mitochondrial genetic code use. The universal arginine codons AGG 
and AGA became in STOP, nevertheless UAG (universal STOP) became in Trp. Further, 
AUA has been reassigned to Met rather than serving as an Ile codon (Smits P. et al., 2010). 
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Codon Universal code Human mitochondrial code 
UGA STOP Trp 
AGA Arg STOP 
AGG Arg STOP 
AUA IIe Met 
Table 1: Comparison of mitochondrial genetic code to universal code (Osawa S et al., 1992) 
I.2. Mitochondria Distribution 
     Mitochondria exist in two interconverting forms; as organelle isolated or/and as extended filaments, networks 
or clusters connected with intermitochondrial junctions (Skulachev VP., 2001). Mitochondria distribution 
is very variable in human cell. The Figure 13 shows primary skin fibroblasts labeled with 
antibodies against DNA, COX2 and/or BrdU under normal conditions. The merge 
DNA/COX2 illustrated the co-localization mtDNA and IMM. Besides, the merge DNA/BrdU 
shows that mitochondria fission and mtDNA replication are not depending mechanisms. 
Thus, mitochondria can replicate its genome without mitochondrial division or mitochondrial 
fission takes place without mtDNA replication.  
 
Figure 13: CoQ10 partially preserves mitochondrial structure of ONH astrocytes against oxidative stress-
induced mitochondrial fission. (Noh YH, et al., 2013).  
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     The Figure 14 shows the mitochondria of ONH astrocytes were stained with MitoTracker 
Red. Control ONH astrocytes exposed to vehicle contained classic elongated tubular 
mitochondria. In contrast, ONH astrocytes exposed to H2O2 contained small rounded 
mitochondria.  
 
     However, ONH astrocytes pretreated with CoQ10 showed a partial preservation of 
mitochondrial morphology compared with the ONH astrocytes exposed to H2O2.   
 
     Furthermore, the mitochondria appearance as network-like regrouped organelles with the 
same functionally is supports by fission and fusion mitochondrial cycles. Also these 
organelles can be morphologically and functionally independent within cells (Noh YH, et al., 
2013).  
 
Figure 14: Mitochondrial DNA localizes to punctuate structures that are distributed throughout the 
mitochondrial compartment. (A) or after a 20 hour pulse with BrdU (B). Insets 1 and 2 depict enlargements of 
the boxed areas. (A) Monoclonal antibodies against DNA label punctuate structures that are distributed 
throughout mitochondria labeled with antibodies against the inner membrane protein COX2. Only a few 
mitochondria appear devoid of DNA-labeling (arrowheads). (B) Antibodies against the thymidine analogue 
BrdU label the nucleus as well as punctuate mitochondrial structures labeled with DNA-antibodies. Some of the 
mitochondrial DNA-positive structures are devoid of BrdU (arrowheads) and very few BrdU-positive structures 
escape detection with DNA-antibodies (arrows). CoQ10, coenzyme Q10; H2O2, hydrogen peroxide. Scale bars, m 
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     Mitochondria are organized into a big network in perinuclear zone where ATP is highly 
required (Collins TJ et al., 2002). (Figure 15) 
 
 
Figure 15: Surface-rendered three-dimensional reconstructions of HeLa cell expressing mito-DsRed1. The 
dashed circle indicates the position of nuclear zone. Scale bars, 5 m (CollinsTJ et al., 2002) 
 
I.3. Mitochondrial fusion and fission  
     Mitochondrial fusion and fission cycles are opposing processes involved in the division 
and the morphology of the mitochondrial population dynamic (Chen H. et al., 2004). 
Mitochondrial fusion is regulated by proteins localized in OMM named mitofusin (Mfn) 
family (Mozdy AD et Shaw, 2003). Mitofusin 2 is involved in ER and mitochondria 
exchange of Ca2+. Mitochondria are in constant remodeling in the cell with half-life between 
6 to 10 days and this variation is because of fusion and fission regulation (Jakobs S., 2006). 
     Fusion and fission events were originally studied in the yeast Saccharomyces cerevisiae 
and allowed the identification of many protein actors as MMM (Mitochondrial Morphology 
and Maintenance). Most of the MMM genes are highly conserved through of species 
evolution and highly implicated in the mitochondrial morphology changes by 
coordinated fusion and fission.  
     These results were confirmed in human mitochondria where it has been shown that fusion 
and fission reactions are involved in matrix exchanges (Legros F et al., 2002 ;  Santel A et 
al., 2003) . These studies confirm that alterations in mitochondrial energy generation, ROS 
production, and apoptosis can all contribute to the pathophysiology of mitochondrial disease 
(Wallace DC., 2002). 
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     Studies in the yeast Saccharomyces cerevisiae have shown that in two mitochondria 
synchronized in fusion and fission events, the fission between external membranes leads to 
the very slow exchange of mtDNA and very rapid exchange of mitochondrial matrixes, 
several cycles of outer and inner membrane fusion and fission are required for 
the exchange of mtDNA damaged (Okamoto K et al., 2005) (Figure 16). 
     Recently, it has been demonstrated that mitochondrial network mobility is associated with 
the cytoskeleton proteins as actin and involved in cytosqueleton dynamic (Kremneva K et 
al., 2013). 
 
Figure 16: Models for mitochondrial fusion in yeast Saccharomyces cerevisiae a) Mfn1 single protein 
interaction and b) Fzo1p-Mgm1p-Ugo1p complex protein interaction (OkamotoK et al., 2005). 
 
     Nevertheless, proteins involved in DNA repair present in matrix can be exchanged very 
fast (Kaufman BA. et al., 2000 ; Nunnari J et al., 1997 ;  Otera H, et al., 2013).  
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     Mutations in MMM lead to modify the mitochondrial profile of subcellular localization 
and mitochondrial morphology.  
     The Figure 17 shows different interactions of MMM complex with proteins that plays 
important role in the cell (Millau JF. et al., 2008). 
 
Figure 17: The MMM complex may mediate at least three processes: actin-mitochondria attachment (left), 
formation of tubular mitochondria (middle), and anchoring of mtDNA nucleoids (right) (Okamoto K et al, 2005) 
I.4. Mitochondrial Functions 
 
Figure 18: The CAC has integrative functions between mitochondrial matrix and cytosolic pathways in ATP 
production. The 3 main sources for ATP production are: carbohydrates, lipids and proteins(Krauss S., 2001). 
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     In the eukaryotic cell mitochondria is involved in several mechanisms such as: Ca2+ 
storage (Leanza L. et al., 2013), thermogenesis (Tine M et al., 2012)) and ATP production. 
The more important mitochondrial function in eukaryotic cell is the ATP production. The 
Figure 18 shows the different pathways for ATP synthesis from various sources such as: 
amino acids, fatty acids and glucose. The protein catabolism is involved directly with CAC in 
the formation of oxaloacetate and 2-oxoglutarate. On the other hand, glucose and fatty acids 
became in acetyl-CoA by glycolysis and ß-oxidation respectively.  
     Finally, the ATP production depends of OXPHOS capacity.  The ATP production (Figure 
19) is generated from a gradient of protons (H+) which is used by the ATP synthase to convert 
ADP and phosphate ions in ATP.  
 
Figure 19: Representation of ATP synthase structure. The F1 unit was localized in mitochondrial matrix and the 
Fo unit in IMM. The synthesis of ATP is depending on the H+ gradient. 
http://www.jpboseret.eu/uploads/images/ATPase.jpg  
 
     This gradient of protons is the result of several oxidation-reduction reactions and depends 
of three important coenzymes such as: nicotinamide adenine dinucleotide (NAD); 
nicotinamide adenine dinucleotide phosphate (NADP); and flavin adenine dinucleotide 
(FAD). OXPHOS is carried out in IMM involving the electrons traffic through respiratory 
chains complexes.  
     During cellular respiration, ATP production is controlled by product excess, ATP being an 
allosteric inhibitor of Cyt-C oxidase (Arnold S. et Kadenbach B., 1997). 
 
 35 
I.5. Mitochondrial diseases  
     The Table 2 shows mitochondrial diseases due to mitochondrial (mt) tDNA and nuclear 
(n) DNA (nDNA) damage 
Genetic and biochemical classification of the mitochondrial diseases 
Genome Gene [mtDNA] Biochemistry Clinical phenotype 
mtDNA   single Δ x prot. synth. KSS; ocular myopathy; PS 
  tRNA Leu(UUR)   ↓ prot. synth MELAS 
  tRNALys   ↓ prot. synth MERRF 
  other tRNAs   ↓ prot synth. multiple phenotypes 
  ATPase6   ↓ATP synth. NARP/MILS 
  
ND1, ND4, 
ND6   ↓complex I LHON 
  ND1, ND4   ↓ complex I myopathya 
  Cyt b   ↓ complex III myopathya 
  COX III   ↓ complex IV myopathya 
nDNA         
  NDUF   ↓ complex I LS 
  SDHA   ↓complex II LS 
  BCS1L   ↓ complex III GRACILE 
  SURF1   ↓ complex IV LS 
  SCO1   ↓ complex IV hepatoencephalomyopathy 
  SCO2   ↓ complex IV cardioencephalomyopathy 
  COX10   ↓ complex IV nephroencephalomyopathy 
  COX 15   ↓complex IV cardioencephalomyopathy 
  ATP 12   ↓ complex V fatal infantile multisystemic 
  TP 
multiple 
Δ ↓ _ MNGIE 
  ANT1 
multiple 
Δ ↓ prot. synth. adPEO-plusb 
  Twinkle 
multiple 
Δ ↓ prot. synth adPEO-plusb 
  POLG 
multiple 
Δ ↓ prot. synth. ad/arPEO-plusb 
  dGK depletion ↓ prot. synth. hepatocerebral syndrome 
  TK2 depletion ↓prot. synth myopathy; SMA 
  TAZ   ↓ cardiolipin Barth syndrome 
  OPA1   ↓ mit. Motility ad optic atrophy  
Table 2: Representation of mitochondrial diseases due to mtDNA and nuclear DNA (nDNA) damage. 
Abbreviations and symbols: Δ, deletion; Ў, decrease, KSS, Kearns–Sayre syndrome; PS, Pearson syndrome; 
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MELAS, Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes; LS, Leigh syndrome; 
MILS, maternally inherited LS; GRACILE, growth retardation, aminoaciduria, cholestasis, lactacidosis, early 
death; adPEO, autosomal dominant progressive external ophthalmoplegia  arPEO, autosomal recessive PEO; 
SMA, spinal muscular atrophy. [mtDNA] indicates changes of mtDNA secondary to nDNA mutations (defects of 
intergenomic signaling). 
 
a Mutations in cyt b and COX genes can also cause multisystemic diseases. 
b Plus refers to proximal weakness, neuropathy, psychiatric disorders, parkinsonism (DiMauro S., 2004).  
     I.5.1. Mendelian: associated with genes of the nuclear genome 
     When DNA disorders concern OXPHOS system, hereditary mitochondrial diseases usually 
affect tissues with high energy needs, like neuromuscular or central nervous system. 
Frequently the deleterious mitochondrial mutations are heteroplasmic, thus wild type and 
mutated forms of mtDNA coexist in the same cell. The mitochondria functions start to shut 
down when a threshold of mtDNA mutation was exceeded. This threshold is variable and 
differs from mutation to mutation: for example 60 to 70% in chronic progressive external 
ophthalmoplegia (CPEO) and probably 95% in the syndromes of mitochondrial 
encephalopathy, myopathy, lactic acidosis, and stroke-like episodes (MELAS), and 
myoclonic epilepsy with ragged red fibers (MERRF) (Tonin Y et al., 2013). The threshold 
effect may explain the tissue-specific patterns of clinical expression (Nonaka I., 1992). 
Consequently, a shift in the proportion between mutant and wild type molecules could 
restore mitochondrial functions (Tonin Y et al., 2013).  
     Mutations in mtDNA that encoded OXPHOS system are related to damage effect in 
respiratory function increasing electron leak and ROS production and therefore mtDNA 
damage. This result guides to vicious cycle that leads to the differential accumulation of 
mutation in mtDNA during aging (Wei YH. et al., 1998). It was show the relationship among 
damages in mtDNA and illnesses apparition such as: MELAS, MERRF, KSS, LHON and 
NARP (Thorburn DR et Rahman S., 1993), where this last one is the consequence of  
ATPase 6 mutation. 
I.5.2. not Mendelian: associated with maternal inheritance 
     The strictly maternal inheritance of mitochondria is the result of the removal of sperm tail 
containing mitochondria prior to egg entry, and the destruction of the sperm mitochondria in 
very little time after fertilization (Sutovsky P, et al., 2000). Thus, this mechanism proposed 
to promote the strictly inheritance of mtDNA in humans and animals (Thompson WE, et al., 
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2003). As well, pedigree schematized by Figure 20 represents a typical maternal mode of 
inheritance of diseases caused by mtDNA mutations (Figure 21). 
Figure 20: Typical pedigree of three filial generations. The black color was used in order to illustrate the illness 
phenotype. The maternal inheritance was shown in the third filial generation where all illness phenotype was the 
maternal origin. Nevertheless, the males (II: 1, 2 and 3) did not transmit the illness phenotype to generation III. 
http://t3.gstatic.com/images?q=tbn:ANd9GcSGVALk3oCWEGsz3rEj0bsWt40YOiWjnonukMHFi_3MonfWDeuh
Agc18lJIvg  
 
Figure 21: Schematic representation of mtDNA representing the protein-coding genes for the seven subunits of 
complex I (ND), the three subunits of cytochrome oxidase (COX), cytochrome b (Cyt b), and the two subunits of 
ATP synthetase (A8/6), the 12S and 16S ribosomal RNAs (12S, 16S), and the 22 transfer RNAs (tRNA) identified 
by one-letter codes for the corresponding amino acids. Abbreviations: FBSN, familial bilateral striatal necrosis; 
KSS, Kearns–Sayre syndrome; LHON, Leber’s hereditary optic neuropathy; MELAS, mitochondrial 
encephalomyopathy, lactic acidosis, and stroke-like episodes; MILS, maternally inherited Leigh syndrome; 
NARP, neuropathy, ataxia, retinitis pigmentosa. In blue the diseases due to mutations that impair mitochondrial 
protein synthesis; and in red diseases because of mutations in protein coding genes (DiMauro S., 2004). 
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II. DNA maintenance 
     Evolution and natural selection have used DNA sequence to store and protect the ¨life 
information¨ to formulate our bodies. The DNA molecules are long complementary chains, 
consisting of 4 bases and referred to as A, G, C and T. The entire information content of a 
human is stored in a long sequence packed into the nucleus and several copies of few circular 
genomes into the mitochondria. Mitochondria genome size represents about 1% of nuclear 
genome size. Mammalian cells stored the genetic information in nucleus with maternal and 
paternal contribution and in mitochondria strictly with maternal contribution ( Trafton A., 
2012). 
Figure 22: Schematic representation of exogenous and endogenous sources of mitochondrial and nuclear DNA 
damages involving different cell responses.  
     In humans, DNA damage has been shown to be involved in a variety of genetically 
inherited disorders, in aging (Finkel T et N J Holbrook NJ., 2000) and in carcinogenesis 
(Hoeijmakers NJ., 2001). 
 39 
     The more often sources of DNA damages such as UV exposure, ionizing radiation, 
chemical exposure, cellular metabolism and replication errors and different cell responses 
(Figure 22).  
     II.1. DNA damage 
     From a structural definition, DNA damage can be divided in 3 main categories: base 
modifications, single or double strand breaks. The amount of lesions that we face is enormous 
with estimates suggesting that each of our 1013 cells has to deal with around 10.000 lesions 
per day  (Lopez-Contreras AJ, et Fernandez-Capetillo O., 2012). 
      The more representative quantities of mutations in human cells are from endogenous 
sources (De Bont R. et van Larebeke N., 2004). 
      They are because of oxidative damages (Ames BN, et al., 1993), depurinations (Lindahl 
T et Nyberg B., 1972), depyrimidinations, single-strand breaks, double-strand breaks, O6-
methylguanines and cytosine deamination. 
     The oxidative damage 8-oxoG is a consequence of reactive oxygen species (ROS) 
generated during oxidative metabolism and its mechanism of DNA repair is highly studied by 
the Base Excision Repair (BER). Analytical measurements of the oxidative DNA adduct 8-
oxo-deoxyguanosine (oxo8dG) show that mtDNA suffers greater endogenous oxidative 
damage than nuclear DNA. The subsequent discovery demonstrated that somatic deletions of 
mtDNA occur in humans. One hypothesis born: ¨The mitochondrial genome is particularly 
more susceptible to ROS damage¨ (Beckman KB. et Ames BN., 1999). This hypothesis 
opened doors in investigations concerning mtDNA ¨protection¨ in 1999.  
     Recently thanks to advances in analytical chemistry it was validated that the major sources 
of DNA damage in human is resulting from endogenous sources such as ROS that not only 
produces 8-OHdG in mtDNA, but also more extensive damages altering DNA chemical 
structure (i.e. strand break) (Wang Z et al., 2013 ; Muralidharan S. et Mandrekar P., 
2013).DSB can be formed because of SSB accumulation, ionizing radiation or clastogenic 
drugs; endogenously, during DNA replication, or as a consequence of ROS generated during 
oxidative metabolism. In addition, DSB are involved in the lost of DNA sequence frequently 
associated with certain pathologies (Lopez-Contreras AJ, et Fernandez-Capetillo O., 
2012). 
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II.2. DNA repair mechanisms 
     II.2.1. Base Excision Repair (BER) 
     The BER system is a multi-step process that repair damage to modified bases following 
oxidation, methylation, deamination, or spontaneous loss of the DNA base itself (A 
Memisoglu A et  Samson L., 2000). 
     The Table 3 shows the more studied human DNA glycosylases 
Human DNA glycosylases 
  Localization   
Enzyme Chromosomal Cellular Mayor sustrates 
UNG 12q23-24.1 N and M 
U in single or double strand DNA, 5-OH-
meU 
SMUG1 12q13.3-11 N  U in single or double strand DNA  
TDG 12q23-24.1 N  
T, U or ethenoC opposite G (preferably 
CpG sites) 
MBD4 3q21-22 N  
T or U opposite G at CpG sites T opposite 
O6-meG 
MYH 1p32.1-34.3 N and M A opposite 8-oxoG, 2-OH-A opposite G 
OGG1 3p26.2 N and M  8-oxoG, 2-OH-A opposite C, fapyG 
NTH1 16p13.3 N and M Tg, DHU, fapyG, 5-OHU, 5-OHC 
NEIL1 15q22-24 N  
As NTH1; also fapyA, 5S,6R Tg isomer, 
8-oxoG 
NEIL2 8p23 N  
Overlap and some differences with 
NTH1/NEIL1 
NEIL3 4q34.2 N  to be determinated 
MPG 16p13.3 N  3-meA, hypoxanthine, ethenoA 
Table 3: List of certain enzymes DNA glycosylases present in nucleus and mitochondria from human cells. 
Chromosomal location, cellular localization and major substrates are represented (Barnes DE et  Lindahl T., 
2004). 
     Endogenous DNA damages were largely as a consequence of unavoidable hydrolysis and 
oxidation. The endogenous ROS production is one main source of damage to DNA present in 
eukaryotes, particularly in aerobic organisms responsible of certain human disease.  
     Most of the single-base damages are repaired through the base excision repair (BER) 
pathway that is initiated by members of the DNA glycosylase family (Barnes DE et Lindahl 
T., 2004). 
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     The DNA glycosylases are responsible for initial recognition of the lesion. They flip the 
damaged base out of the double helix, and cleave the N-glycosidic bond of the damaged base, 
leaving an apurinic/apyrimidinic (AP) site. (Figure 23) There are two categories of 
glycosylases: monofunctional glycosylases have only glycosylase activity, whereas 
bifunctional glycosylases also possess AP lyase activity.  
     Therefore, bifunctional glycosylases can convert a base lesion into a single-strand break 
without the need for an AP endonuclease. In human cells, oxidative pyrimidine lesions are 
generally removed by hNTH1, hNEIL1, or hNEIL2, whereas oxidative purine lesions are 
removed by hOGG1. At least 11 distinct mammalian DNA glycosylases are known.  
     One example of DNA bifunctional glycosylases is OGG1 that recognizes 8-oxoG paired 
with cytosine in DNA. Similar fonction was identified in Escherichia coli as MutM (Fpg) 
(van der Kemp PA. et al., 1996). 
     BER initiated by a DNA glycosylase leaves an abasic site. Depending on the numbers of 
nucleotides eliminated (short or long excision), BER will progress either by short-patch repair 
or long-patch repair using different proteins in each mechanism (Krokan HE et al., 2013). 
     After glycosylase intervention, the protein AP endonuclease (APE1) cleaves the AP site to 
yield a 3' hydroxyl adjacent to a 5' deoxyribosephosphate. This excision can be carried out by 
bifunctional glycosylases like OGG1.  
     In order to facilitate ligation 3’-5’ ends, the empty DNA zone is completed by the DNA 
Polymerase. The Pol β is the main human polymerase involved in short and long-patch BER. 
In short-patch pathway, BER ligation is permitted by DNA ligase III that catalyzes, in 
presence of two partners XRCC1 and Poly ADP ribose polymerase 1 (PARP1), the nick-
sealing step.  
     For the long-patch pathway, DNA ligase III is replaced by DNA ligase I (Rice PA., 1999 ;  
Braithwaite EK et al., 2005).  
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.     Also the Figure 23 illustrates short-patch and long-patch BER pathways in the nucleus 
and mitochondria.  
 
Figure 23: Short-patch and long-patch BER pathways in the nucleus and mitochondria of mammalian cells. The 
major factors involved are highlighted. Factors common to both compartments are displayed with an orange 
background, factors specific for the nucleus are on a blue background and factors specific for mitochondria are 
on a yellow background. *DNA2 is present in the nucleus but its putative role in nuclear BER is not clear so far. 
APEX1, AP endonuclease; POLș, ț, Ȝ, Ț, DNA polymerase ș, ț, Ȝ, Ț; RFC, replication factor C; 
PCNA, proliferating cell nuclear antigen; DNA2, endonuclease/helicase; FEN1, flap endonuclease 1; LIG1, 
LIG3, DNA ligase 1, 3; XRCC1, X-ray crosscomplementing protein-1(Boesch P. et al., 2011). 
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     As guanine oxidized (8-oxoG (GO)) Figure 24 appears structurally close to thymine, DNA 
polymerase introduces adenine in complementary DNA strand. This Adenine: 8-oxo-G 
mispair is proficiently recognized by the MutY glycosylase homologue (MUTYH). If 
Adenine is removed by MUTYH, the BER will proceed, the DNA will be repaired. If 
unrepaired, a new mutation is created.  
 
Figure 24: Schematic representation oxidative damage of guanine. http://mol-
biol4masters.masters.grkraj.org/html/DNA_Damage_And_Repair2-
Types_of_Damages_and_Effects_files/image030.jpg 
 
     The Figure 25 shows the various repair mechanisms observed for 8-oxo-G following ROS 
attack leading to the formation of C: 8-oxo-G base pairs: 
     Left column: These can be recognized by OGG1, which excises the 8-oxo-G and incises 
there sulting AP-site by ș-elimination, giving rise to a 3’ddR 5P and a 5’P residue. This 3’ 
sugar phosphate is then removed by APE1, yielding in a 1 nucleotide gap with a 3’OH and a 
5’ P. Subsequently, pol ș catalyzes the insertion of a G opposite the templating C in this SP-
BER pathway, and ligation by XRCC1/DNA ligase I leads to restoration of an intact, 
correctly base-paired double-stranded DNA again. Middle column: If the C: 8-oxo-G base 
pairs are not recognized before S-phase by OGG1, or they arise through oxidation in S-phase, 
the replicative pols will often incorporate a wrong A opposite8-oxo-G, giving rise to A: 8-
oxo-G mispairs. If these are not corrected, another round of replication will lead to a CGЍAT 
transversion mutation. Right column: The A: 8-oxo-G base pairs can be recognized by 
MUTYH, which catalyzes the excision of the wrong A from opposite 8-oxo-G, leading to the 
formation of an AP site. This AP site is further processed by APE1, which results in a 
1nucleotide gap with 3’ OH and 5’ dRP moieties. The incorporation of the correct C opposite 
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8-oxo-G and one more nucleotide is performed by pol Ȣ in collaboration with the cofactors 
PCNA and RP-A, thus performing strand displacement of the downstream DNA strand. FEN1 
cleaves the 5’ flap, leading to a 5’P moiety, which can be ligated by DNA ligase I to yield an 
intact C: 8-oxo-G containing double-stranded DNA. This C: 8-oxo-G is then again substrate 
for OGG1-mediated removal of 8-oxo-G (left column) (Markkanen E, et al., 2013). 
 
Figure 25: MUTYH-initiated BER of A:8-oxo-G lesions(Markkanen E, et al., 2013).  
 
II.2.1.1. BER in mitochondria 
     In Figure 26, Boesch and collaborators summarized the dialogue between nucleus and 
mitochondria in mtDNA repair under mitochondrial oxidative stress in human and plants 
cells.  
     They schematized how probably post-translational modifications in DNA repair proteins 
can be involved in mitochondrial damage signals.  
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     One of the more important function of mitochondria is ATP production involved ROS 
generation and damage of mtDNA repair mechanisms are unclear until nowadays. Due to 
ROS level in mitochondria BER mechanism remains like one of the more often studied 
mechanism (Lopez-Contreras AJ, et Fernandez-Capetillo O., 2012).  
 
     They demonstrated Figure 27 that mitochondrial damage signaling may compete with 
nuclear damage signaling for the recruitment of monofunctional and bifunctional glycosylases 
such as UNG1, MUTYH, OGG1, NTHL1, NEIL1 and NEIL2 where most of the BER 
proteins are also membrane-bound.  
 
     The Short-patch BER, by example, is mediated by OGG1 for 8-oxoG repair in 
coordination with APEX1, the DNA polymerase POL Ț and the DNA ligase (LIG3).  
 
     Besides, CSB recruits the BER proteins to the membrane; CSA and CSB interact with the 
single-stranded DNA-binding protein SSB and the glycosylase; the tumor suppressor p53 
stimulates the glycosylase and POLȚ; PARP-1 modulates BER.  
 
     Long patch BER pathway is carried out in addition the endonuclease/helicase DNA2 and 
the endonuclease FEN1.  
 
     The transcription factor and packaging protein TFAM binds with high affinity to damaged 
DNA; TFAM binding is modulated by p53 and the thioredoxin TRX2 and p53 itself can 
hydrolyse oxidized nucleotides at DNA 3′-ends and the reaction is enhanced by SSB 
(Lopez-Contreras AJ, et Fernandez-Capetillo O., 2012). 
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Figure 26: Organization of oxidative DNA damage repair processes and factors in mammalian mitochondria, 
Main repair enzymes are in green; further factors are in yellow or purple; core DNA-interacting proteins are in 
blue. Modified from (Boesch P. et al., 2011). 
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Figure 27: Mitochondrial BER in mammalian cells. Three different sub-pathways of SP-BER converge at the 
gap filling step. SP-BER (left) and LP-BER (right) converge at the nick-sealing step. In addition to FEN1, DNA2 
is required for efficient flap processing during LP-BER in mitochondria (Lopez-Contreras AJ, et Fernandez-
Capetillo O., 2012).  
 
II.3.2. Single or double strand breaks repair 
     In mammalian cells single strand break can be repaired by BER mechanism and DSB by 
Non-Homologous End Joining (NHEJ), and Homologous Recombination (HR), (Figure 28) 
which is only available S and G2 phases when a sister chromatid can be used as a template for 
the repair reaction (Lopez-Contreras AJ, et Fernandez-Capetillo O., 2012).  
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Figure 28: Schematic representation of DSBs repair mechanisms. A) NHEJ.and B) HR. Both mechanism are in 
response to ROS DNA damage. B) HR (Lopez-Contreras AJ, et Fernandez-Capetillo O., 2012). 
 
II.3.2.1. Non-homologous end-joining (NHEJ)  
     The NHEJ represents the major pathway (concerning HR limitation into cycle cell) for 
DSBs repair in multicellular eukaryotes involving at least six DNA repair proteins such as: 
Ku, DNA protein kinases, artemis, polymerase (mu and lambda), XLF: XRCC4 and DNA 
Ligase IV.  
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     DNA damage as DSBs can be detected by heterodimer Ku70/Ku80 that keeps the right 
structure of the two DNA ends and guide to DNA-PK recruitment. Consequently, DNA-PK 
phosphorylates and activates the NHEJ effector complex (ligase IV/XRC44/XLF) that finally 
religates the broken DNA. The accessory factors are the mammalian polynucleotide kinase 
(PNK), aprataxin (APTX) and the Polynucleotide Kinaseand Aprataxin-like Forkhead-
associated (PALF). (Figure 29). This flexibility permits NHEJ to function on the wide range 
of possible substrate configurations that can arise when double-strand breaks occur, 
particularly at sites of oxidative damage or ionizing radiations (Weterings E et al., 2004 ;  
Lieber MR et al.,  2008 ;  Lieber MR., 2010). 
  
 
 
Figure 29: Interactions between NHEJ proteins. Physical interactions between NHEJ components are 
summarized (Rooney S, et al., 2004). 
  
      DSB repair by NHEJ is associated with limited or extensive additions or deletions of 
nucleotides at the generated junction, which alters the original DNA sequence at the damaged 
site. In addition, it is notable that vertebrates have extended their pool of end joining activities 
with the protein kinase DNA-dependent (DNA-PKcs), which play a role in this shift from HR 
to NHEJ (Mladenov E et Iliakis G., 2011). 
     Nevertheless DSB can be repaired throughout the cell cycle by non-homologous end 
joining (NHEJ) or microhomology mediated end joining (MMEJ), which repair breaks 
regardless of DNA sequence and therefore are error prone. In NHEJ DNA ends are ligated 
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directly, sometimes after trimming by nucleases or filling in by polymerases. NHEJ is 
initiated by the binding of Ku70/80, which recruits downstream factors including DNA-PKcs 
and Artemis. Ligation of ends is carried out by the XRCC4–LigaseIV complex. In some 
circumstances one or more of the broken ends is refractory to Ku mediated NHEJ. In this case 
repair can proceed by nucleolytic processing and resection of the 3-end until a short region of 
complimentary bases is revealed (in blue). Pairing of this microhomology stabilizes the 
broken ends, displaced flaps are removed (by Fen1 or Rad1/Rad10) and ligation can occur 
(Hiom K., 2010). 
II.3.2.2. Homologous recombination (HR) 
     Homologous recombination is a universal process, conserved from bacteriophage to 
human, which is important for the repair of double-strand DNA breaks. The general process is 
as follow : the free ends of a DSB are first processed by an exonuclease. The ATM kinase is 
recruited to DSB via an interaction with the MRN (Mre11-Rad50-Nbs1) complex. Once at the 
break, ATM that becomes activated, phosphorylating multiple substrates. In a reaction that 
depends in multiple endo and exonuclease activities. The exposed 3’ ssDNA tails are coated 
by single-strand DNA binding proteins (SSBs) to prevent the formation of secondary 
structures. The recombination mediator, (not show in figure) Rad52 then displaces SSB and 
recruits the Rad51/RecA-type recombinase to form presynaptic helical nucleoprotein 
filaments. These filaments then initiate homology search and catalyze ATP-dependent strand 
invasion within duplex DNA templates. The invading strand provides a free 3’ end for 
priming DNA replication that allows the restoration of genetic information missing from the 
dsDNA breaks. The Rad52 protein has a second function in this pathway, which is to capture 
the second end through its single-strand annealing activity. After DNA synthesis and ligation, 
double Holliday junctions are formed.  
 
     The Holliday junctions can be resolved by different molecular strategies with or without 
DNA strand crossover. Without the capturing of the second end by Rad52, the invading strand 
may be dissociated from the D-loop and reannealed to the ssDNA on the second end, a 
process known as synthesis-dependent strand annealing (Chen XJ., 2013). 
     Recently studies reveal a recombination protein of likely bacteriophage origin in 
mitochondria and support the notion that recombination is indispensable for mtDNA integrity 
(Mbantenkhu M, et al., 2011). 
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II. 4. DNA repair in mitochondria 
     From 1974 Clayton and collaborators show that mitochondria are unable to repair 
pyrimidine dimers and some types of alkylation damage (Miyaki, et al., 1977). Several years 
took for discovery of mitochondrial BER (Pettepher, et al., 1991). Recently Gredilla 2010 
and Boesch and collaborators in 2011 proved that DNA repair mechanisms are present in 
nucleus but are also in mitochondria illustrating different pathways which need further 
confirmation with a hatched background. Just the Nucleotide Excision Repair (NER) pathway 
was not detected in mitochondria. Nevertheless Homologous recombination (HR) and Non-
homologous end-joining (NHEJ) were associated with Double Strand Break Repair (DSBR) 
of mtDNA. The Figure 30 shows the DNA repair pathways highly conserved among nucleus 
and mitochondria (Wilson S, et al., 2012). The Figure 31 shows a possible PARP action in 
strand break with blocking groups at one or both exposed ends is unable to be repaired by 
simple short patch-BER.  
Figure 30: Nuclear and mitochondrial DNA repair shares common proteins. However not all nuclear DNA 
repair pathways are present in the mitochondria. BER proteins, isoforms of nuclear relatives (Wilson S, et al., 
2012). 
 
     The detection method may influence the type of lesion processing, either damage reversal, 
if a specific enzyme such as APTX or TDP1 is able to resolve the lesion, or damage excision, 
a more generic pathway that excises the DNA damage using the long patch-BER pathway.  
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     In the mitochondria long-patch BER dependant multi nucleotide excision appears to be 
driven by EXOG as part of an APE1 complex however the presence of FEN-1 and DNA2 in 
the mitochondria suggests a secondary long patch-BER pathway, potentially to excise lesions 
resistant to EXOG activity. After the lesion has been resolved nucleotides are inserted by 
polymerase 
Wilson S, et al., 2012).  
 
 
Figure 31: Resolution of persistent mitochondrial single strand breaks (Wilson S, et al, 2012).  
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a). Proteins involved in mtDNA strands breaks repair   
     The Table 4 illustrates some proteins involved in mtDNA recombination pathways in 
yeast, mammalian and plant. In 2008, our group demonstrated that bleomycin-induced DSB 
were efficiently repaired in Drosophila mitochondria using S2 cells, with a comparable rate to 
that was observed for nuclear repair (Morel F et al., 2008). 
  
Organism and protein Molecular function Mutant phenotype on recombination 
Yeast     
      
Abf2 high-mobility-group Increases Holliday junctions,  
   protein primarily for mtDNA packaging reduces repeat-mediated recombination 
Exo5 5’-3’ exonuclease Unknown 
Hmi1 3’-5’ DNA helicase mtDNA fragmentation 
Mgm101 Single-strand annealing protein Decreases repeat-mediated recombination 
Mhr1 Homologous pairing in vitro Decrease gene conversion 
MRX complex 5’-3’ exonuclease Decrease repeat-mediated recombination 
Msh1 Mismatch repair-like protein Increases repeat-mediated recombination 
Nuc1 Endo/exonuclease Decreases mtDNA recombination 
Pif1 5’-3’ DNA helicase Reduce recombination in p+ x p- crosses 
Rim1 Single-strand annealing  Suppresses pif1 mutation 
Table 4: Proteins known to affect DNA recombination in yeast, mammalian, and plant mitochondria (Chen., 
2013) . 
 
     Normally, the Yeast Mgm101 protein (Figure 32) is involved in single-strand annealing 
but in response to oxidative stress or to other signals which generate dsDNA breaks, Mgm101 
can be involved in dsDNA breaks repair pathways in mitochondria (Chen., 2013).  
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Figure 32: Molecular modeling of the Mgm101 core domain (from A115 to V237) based on the Rad52 structure 
(1H2I). (A) The positions of N150, F153, and F235, which are highly conserved in Rad52-related proteins, are 
highlighted. Also indicated are C216 and C217, which form a putative redox sensor for regulating Mgm101 
function. (B) Surface representation model of a 14-mer ring formed by Mgm101115-237 (Chen., 2013).  
 
 
     The Figure 33 shows that Mgm101 can be activated by ROS and guide mitochondria to 
repair mtDNA by pathways such as HR and NHEJ (Chen., 2013). 
 
 
Figure 33: A model for activation of Mgm101 in mtDNA repair. The Mgm101 rings are proposed to be the 
storage form of the protein in mt-nucleoids. In response to oxidative stress or other signals, the C216/C217 
cysteine pair is modified. This may induce structural remodeling in the rings, which stimulates ssDNA binding 
and the repair of dsDNA breaks (Chen., 2013).  
  56 
     The Figure 34 shows the gene duplication that occurred before the divergence of archaea 
and eukaryotes giving rise to two lineages, RADandRADrecA has remained as a single-
copy gene. In eukaryotes, both RADand RADgenes experienced several duplication 
events, but, in archaea, they remained as single-copy genes.  
 
     Eukaryotic recA genes originated from proteobacteria (recAmt) and cyanobacteria 
(recAcp) recA genes after two separate endosymbiotic events. recAmts were subsequently lost 
in the ancestors of animals and fungi (Lin Z. et al., 2006). 
Figure 34: A model of the evolutionary history of recA/RAD51 gene family (Lin Z.et al., 2006).  
 
II.5. DNA repair and pathologies 
     II.5.1. BER and cancer 
     Disorders in DNA repair pathways lead to cancer predisposition, predicting that shut of 
BER efficacy could contribute to the development cancer diseases. Indeed, somatic mutations 
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in Pol β have been found in 30% of human cancers (Starcevic D, et al., 2004). Mutations in 
the DNA glycosylase MYH are also highly implicated to colon cancer (Gryfe R., 2009). 
     Genetic variations of APE1 have been shown to influence an individual's susceptibility to 
carcinogenesis. Also, the genetic polymorphisms of APE1 are associated with the risk of renal 
cell carcinoma (Cao Q, et al., 2011) and with breast cancer progression (Kang H. et al., 
2013). 
     Recently, it was published the genetic polymorphisms of OGG1 associated with pancreatic 
and colorectal cancer risks (Chen H. et al., 2013 ; Su Y, et al., 2013).  
     II.5.2. HR, NHEJ and cancer  
     Heat shock is an effective radiosensitizer. A combination of heat with 
ionizing radiation (IR) is one of the more frequent strategies in the treatment of human cancer. 
Heat exposure causes extensive death of irradiated cells. DNA double strand breaks (DSBs) 
are the main cause for IR-induced cell death. For this reason, inhibition of DSB processing 
has long been considered a major candidate for heat radiosensitization. However, it has been 
shown that radiosensitization of mutants with defects in DSB repair failed to find a relation 
between DSB repair pathway and radiosensitization (Iliakis G., et al., 2008). 
     Pancreatic ductal adenocarcinoma (PDAC) is one of the major causes of death in human’s 
cancers. PDAC is extremely resistant to currently available therapeutics. PDAC harbors high 
levels of spontaneous DNA damage. Inhibition of NHEJ repair results in further accumulation 
of DNA damage, growth inhibition and apoptosis even without DNA damaging agents. In 
response to radiation, NHEJ pathway rapidly repairs DNA double strand breaks in PDAC 
cells. Because of that, inhibition of NHEJ has been considered into PDAC therapeutic 
approaches (Li YH et al., 2012). 
     II.5.3. NHEJ and immunity  
     XRCCA-like factor (XLF) plays a fundamental role nonomologous end joining DNA 
double-strand break repair (NHEJ). This system is required to repair DNA break occurring 
during lymphocyte development. Mutations in XLF cause a progressive lymphocytopenia. It 
has been reported that XLF-deficient murine cells show no detectable defects in Variable, 
Diverse, and Joining (V(D)J) recombination.  
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     In contrast with the moderate role of ATM kinase and its H2AX substrate for V(D)J 
recombination in WT cells, it has been reported that both factors become essential in XLF-
deficient lymphocytes. p53-binding protein 1 (53BP1) is also involved in ATM. 53BP1 
deficiency causes a small reduction of peripheral lymphocyte number. The severe defects in 
end joining are carries out during chromosomal V(D)J recombination. V(D)J recombination 
which is required for lymphocyte development, is initiated by introduction of DNA double-
strand breaks.  
     This is catalyzed by the RAG endonuclease and occurs between the conserved 
recombination signal sequences (RSS) and the participating germ-line V, D, or J gene 
segments. After, ubiquitously expressed NHEJ factors join the two 5′-phosphorylated blunt 
signal ends forming a coding join (CJ) (Rooney S.et al., 2004). The heterodimer KU70-KU80 
(KU86 in human) directly binds DSB ends, recruits and activates other NHEJ factors. DNA-
KU complex activates the endonuclease function of Artemis for end process during V(D)J 
recombination (Lieber., 2010).  
     Finally a complex including ligase 4 and XRCC4 factor ligates the ends together. 
Although XLF binding to XRCC4 was known, its  exact function needs to be elucidated 
(Ahnesorg P, et al., 2006 ; Buck D et al., 2006 ;  Andres SN. et al., 2007).  
     As C-NHEJ is essential for V(D)J recombination, defects in previous characterized NHEJ 
factors completely block lymphocyte development at the progenitor stage and also cause 
T− and B− severe combined immunodeficiency (T−B−SCID) in both human and mouse models 
(Rooney S. et al., 2004 ; Lieber., 2010 ; Li G. et al., 2008). XLF mutations cause a less 
severe lymphocytopenia than SCID in human patients. In the case of XLF-deficient mice, the 
lymphocytes numbers are reduced with not stage-specify blockade. In agreement, 
chromosomal V(D)J recombination occur normally in XLF-deficient lymphocyte but not in 
XLF-deficient murine embryonic stem cells. This observation suggested that more than one 
repair pathway(s) might exist in developing lymphocytes to compensate XLF deficiency 
during V(D)J recombination (Lieber., 2010).  
     Recently, it has been reported that chromosomal V(D)J recombination in XLF-deficient 
lymphocytes requires ATM and its kinase activity (Zha S. et al., 2011) ATM kinase is a 
master regulator of the DNA damage response. Although ATM promotes efficient DNA 
repair during CJ formation (Bredemeyer A L et al., 2006),  ATM is not required for V(D)J 
recombination and lymphocyte development (Barlow C et al., 1996).  
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     Additionally, it was demonstrated that blockade of IgG in bladder cancer cell T24 resulted 
in up regulation of cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) 
(Liang PY, et al., 2013). The Poly(ADP-ribosyl)ation is considered a reversible post-
translational protein modification and is involved in the regulation of a number of biological 
functions such as: maintenance of genomic stability, transcriptional regulation, energy 
metabolism, centromere function, telomere dynamics, mitotic spindle formation during cell 
division, concluding, poly(ADP-ribosyl)ation is involved in aging and cell death (Aguilar-
Quesada R. et al., 2007 ;  Lee HH et al., 2013). 
     III.1. Poly(ADP-ribose) metabolism 
     The metabolism of Poly(ADP-ribose) is a dynamic process mediated by ARTs and  
poly(ADP-ribose) glycohydrolase (PARG) enzymes (Bonicalzi ME et al., 2005). Polymers 
with chain lengths about 200 ADP-ribose units are rapidly degraded by PARG poly(ADP-
ribose) and / or ADP ribosyl-acceptor hydrolase (ARH3) (Isabelle M et al., 2010). 
 
 
Figure 35: Poly(ADP-ribosyl)ation reaction activated by DNA strand breaks. PARP-1 and PARP-2, rapidly 
recognizes DNA-strand breaks generated by genotoxic agents leading to their activation (Yelamos J et al., 
2011).  
 
     The Figure 35 shows the Poly(ADP-ribosyl)ation regulation reversed by the activities of 
poly(ADP-ribose)polymerase PARP and poly(ADP-ribose) glycohydrolase (PARG) in 
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nucleus and ADP ribosyl-acceptor hydrolase (ARH3) and in mitochondria 
(Pankotai E, et Lacza Z., 2009).  
 
     In nucleus the proteins targeted such as H1, H2B and TRF2 are involved in numerous 
biological processes, including DNA repair, chromatin structure and transcription. Poly(ADP-
ribosyl)ation of acceptor proteins has functional consequences such as DNA-break signaling, 
chromatin relaxation and recruitment of DNA repair proteins (Yelamos J et al., 2011).  
 
     Recently, in order to clarify the Poly(ADP-ribose) metabolism, using siRNA in PARG 
knock-down it was shown that the poly(ADP-ribosyl)ation of proteins in the cells was lost, 
revealing that  PARP1 expression and  activity is involved with PARG expression in 
knockdown cells. (Uchiumi F, et al., 2013) 
 
     Thus, poly(ADP-ribose) in a cell is regulated under the control of PARP1/PARG gene 
expression balance. Structural and enzymological evidences of PARP family lead to propose 
a new consensus nomenclature for all ADP-ribosyltransferases (ARTs) based on the catalyzed 
reaction and on structural features. ARTs members are classified in two big subfamilies such 
as: the DNA-dependent PARPs, (PARP1, PARP2 and PARP3) and the tankyrases (Hottiger 
MO et al., 2010). 
 
     From the 18 member of ARTs described (Figure 36), PARP-1 accounts for more than 
90% of the poly(ADP-ribosyl)ating capacity of the cells  The domains of each member are 
indicated: According to protein sequence from NH2 to COOH terminal in PARP1 The ART 
domain is the catalytic core required for basal ART activity. The WGR domain named after a 
conserved central motif (W-G-R) is also found in a variety of polyA  
 
     The PARP regulatory domain (PRD) might be involved in regulation of the PARP-
branching activity. polymerases and in proteins of unknown function. The sterile alpha motif 
(SAM), a widespread domain found in signaling and nuclear proteins, can mediate homo- or 
heterodimerization. The ankyrin repeat domains (ARD) mediate protein–protein interactions 
in diverse families of proteins. The vault protein inter-alpha-trypsin (VIT) and von 
Willebrand type A (vWA) domains are conserved domains found in all inter-alpha-trypsin 
 61 
inhibitor (ITI) family members. The WWE domain is named after three conserved residues 
(W-W-E), and is predicted to mediate specific protein–protein interactions in ubiquitin- and 
ADP-ribose conjugation systems. The Macro or A1pp domains are structurally related to the 
catalytic domain of enzymes that process ADP-ribose-1′-phosphate, a reaction product 
derived from ADP-ribose 1′-2′ cyclic phosphate generated by Terminal Phosphotransferase 
(TpT). The Macro domain can serve as ADPr or O-acetyl-ADP-ribose binding module The 
BRCT domain (BRCA1 carboxy-terminal domain) (Amé JC, et al., 2004). 
 
Figure 36: Schematic comparison of the ARTD (PARP) family. ZF: zinc finger domains. SAP: 
SAF/Acinus/PIAS-DNA-binding domain, MVP-ID: Major-vault particle interaction domain, NLS: nuclear 
localization signal. CLS: centriole-localization signal. HPS: Histidine-proline-serine region. RRM is an RNA-
binding/recognition motif. UIM: ubiquitin interaction motif. MVP-ID: M-vault particle interaction domain. 
TPH: Ti-PARP homologous domain. GRD: glycine-rich domain. Within each ART domain, the region that is 
homologous to the PARP signature (residues 859–908 of PARP1) as well as the equivalent of the PARP1 
catalytic E988 is shaded. The WWE domain is a protein–protein interaction motif. TM: transmembrane domain 
(HottigerMO et al., 2010). 
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III.2. The structure-function of human PARP-1 
     The member PARP-1 has been studied most extensively; it is a monomeric enzyme, of 
116-kDa highly conserved (Amé JC, et al., 2004), (Figure 37). This molecule is involved in 
the polyADP-ribosylation carried out by poly(ADP-ribose)polymerase (PARP) enzymes, of 
which the first discovered and most important is PARP-1, a very highly abundant nuclear 
protein found in higher eukaryotes (Amé JC, et al., 2004). The main targets for addition of 
PAR by PARP-1 are histones and PARP-1 itself (Adamietz P., 1987 ;  Poirier GG et al., 
1982). although there are many other targets including HMG proteins (Tanuma S, et al., 
1983), topoisomerase I (Krupitza G et Cerutti P., 1989) and p53 (Kanai M et al., 2007).  
III.2.1. PARP-1 structure 
 
 
Figure 37: The domain structure of PARP-1, showing the DNA-binding, the automodification and catalytic 
domains (domains A–F). The PARP signature sequence (in dark blue within the F catalytic domain) is the most 
conserved between the PARPs. Zn I and Zn II: Zinc-finger motifs. Zn III: Zinc ribbon domain. NLS nuclear 
localization signal; BRCT BRCA1 carboxy terminus (Mégnin-Chanet F, et al., 2010). 
 
     According with Figure 37 the DNA binding domain contains three zinc finger motifs, the 
two first enclosing the motif A showed in Figures 38 and 39 by F1 and F2 domains 
(Eustermann S et al., 2011) and the third isolating zinc finger motifs is localized among the 
motifs B and C. The two first zinc finger domains are responsible for DNA interaction and 
genome screening, while the third zinc finger domain is involved in PARP-1 dimerisation 
(Langelier MF et al., 2008). 
     Motif B contains a bipartite nuclear localization signal (NLS) responsible for the nuclear 
addressing of PARP-1, and also, motif B enclose a caspase3/7 cleavage site (Eustermann S. 
et al., 2011), Figures 40 and 41).  
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Figure 38: Schematic representation 3D of PARP-1 zinc fingers. F1 and F2 were structurally independent. 
(modified from (Eustermann S. et al., 2011)  
 
Figure 39:  PARP-1 fingers F1 +F 2 form a 1:1 monomeric complex with DNA single-strand breaks modified 
from (Eustermann S. et al., 2011).  
 
 
Figure 40: (a) Human PARP-1 clevage site. (a) During apoptosis, PARP-1 is cleaved by caspase-3 (common 
with caspase7) into a 24-kDa and an 89-kDa fragment. (Modified from Eustermann S. et al., 2011). 
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     The automodification domain contains a BRCT, D and E motifs. BRCT motif guides to 
PARP-1 interaction with similar motif in proteins such as: XRCC1, BRCA-1 and BRCA-2. 
The catalytic domain with motif F is the smallest PARP-1 fragment retaining catalytic 
activity. The NAD+ acceptor sites is named PARP signature motif and it is a sequence of 49 
amino acids highly conserved through the evolution (Elkoreh G. et al.,2012). 
 
 
Figure 41: Relationship between caspase-3 activation and PARP cleavage during apoptosis (Liang PY. et al., 
2013).  
 
 III.2.2. PARP-1 in DNA repair 
 
Figure 42: Schematic representation of chromatin superstructure relaxation due to PARP action: relationship 
between SSB and PARP-1 activation. The position of covalent histone-tail poly(ADP-ribosyl)ation is indicated 
below the sequences of rat histones (Schreiber V et al., 2006). 
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     PARP-1, with the N-terminal two first zinc finger motives, makes genome screening until 
DNA-nicks detection (Eustermann S et al., 2011). This results into auto-posttranslational 
modification (auto ADP-ribosilation) but also histones poly(ADP-ribosyl)ation.  
 
     The Figure 42 shows poly(ADP-ribose) synthesis at the DNA-damage site triggers both 
the immediate recruitment of the SSB repair (SSBR) scaffold protein XRCC1, but also the 
relaxation of chromatin superstructure as mediated by poly(ADP-ribosyl)ation of histone H1 
and H2. This modification facilitates repair enzymes access to the DNA lesion and interaction 
with XRCC1. 
 
III.2.3. PARP-1 role in few DNA repair pathways  
     PARP-1 has a role in SSBs repair. PARP-1 knock down with siRNA or PARP-1 activity 
inhibition with small molecules reduce SSB repair and the absence of PARP1 increase the 
quantity of DSBs.  
     The SSB accumulated is transformed in DBSs as well, HR system can be modulated due to 
the new level of DBSs, thus PARP-1 can be involved in different mechanisms such as: BER, 
SSB, NHEJ and HR mechanisms (Godon C, et al., 2008). 
 
III.3. The structure-function of PARP-2 ambiguity  
     PARP-2 was discovered as a result of the presence of residual DNA-dependent PARP 
activity in embryonic fibroblasts derived from PARP-1-deficient mice (Shieh WM et al., 
1998). 
     The crystal structure of the murine PARP-2 is very similar to that of PARP-1, with the 
difference that PARP-2 hasnot Zinc-finger motifs, (Figure 43). This structural difference 
leads the acceptor site that reflects differences in terms of substrates (Oliver AW et al., 
2004). 
     The catalytic domain has the strongest resemblance to that of PARP-1 with 69% similarity. 
PARP-2 carries out multiple modifications in histone H2B while PARP-1 preferentially 
makes only one modification in H1(Poirier GG, et al., 1982).  
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Figure 43: The domain structure of PARP-2, showing the PARP signature sequence (in dark blue within 
the F catalytic domain). NLS nuclear localization signal; NoLS nucleolar localization signa (Mégnin-Chanet F, 
et al., 2010).  
  
     PARP-2 whose function is still not clear, acts as a chromatin modifier as mentioned above. 
PARP-2 interacts with PARP-1 and shares common partners involved in SSBR and BER 
pathways: XRCC1, DNA polymerase  -1 and PARP-2 also 
interact with proteins involved in the kinetochore structure and in the mitotic spindle 
checkpoint. Also remodeling of chromatin by PARylating histones and relaxing chromatin 
structure, thus allowing transcription complex to genes access (Bürkle A, et al., 2005). 
III.2.2. The structure-function of PARP-3 
     PARP-3 has been identified as a core component of the centrosome preferentially located 
at the daughter centriole and interferes with the G1/S cell cycle progression (Augustin A, et 
al., 2003). 
    Of all ARTs, PARP-3 displays the smallest N-terminal domain with only 54 residues 
responsible for the centrosomal localization. Besides, PARP-3 shares with PARP-1 two 
domains, E and F, which display a 61% similarity. Functionally, PARP-3 activity is annulated 
using the PARP-1 inhibitor (3-aminobenzamide), thus, PARP-3 shares with PARP-1 function 
in DNA damage surveillance (Kanai M, et al., 2003). 
     Recently, PARP-1, PARP-2 and PARP-3 are characterized as DNA-dependent PARPs 
with presence of special catalytic domain integrated by histidine–tyrosine–glutamate (H-Y-E) 
named ¨catalytic triad¨ of PARP (Scarpa ES, et al., 2013). 
III.3. Tankyrases  
     Tankyrases (ART-5 and 6 in Figure 36) contain large ankyrin domain repeats that mediate 
protein–protein interactions using a 33-residue sequence motif. This sequence was first 
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identified in yeast and Drosophila and was named for the cytoskeletal protein ankyrin, which 
contains 24 copies of this repeat. Subsequently, ankyrin repeats have been found in many 
proteins spanning a wide range of functions.which facilitate target selection and activation 
(Mosavi LK. et al., 2004). 
     Tankyrase1 (TRF1-interacting, ankyrin-related ADP-ribose polymerase), ART5 was 
identified as a partner of the human telomeric protein TRF1 in a two-hybrid screening 
(Sbodio JI. et Chi NW., 2002). Thus, its functions are involved in telomere length regulation 
in mitotic division (Hsiao SJ et al., 2008). Accordingly, Tankyrase-1 (ART-5) and 
Tankyrase-2 (ART-6) show multiple subcellular localizations such as: telomeres, nuclear 
pores, pericentriolar material during mitosis, and Golgi complexes. It was hypothesized that 
tankyrases are involved in energy homeostasis in mammals, thus present in mitochondria 
(Yeh TY, et al., 2009).  
III.4. Other PARPs  
     The TIPARP: containing the TPH domain (Cys-Cys-Cys-His) and Trp-Trp-Glu domain, 
(Figure 36) which can exhibit PAR-binding activity (Katoh M, et Katoh M., 2003). 
     The macroPARPs: containing macrodomain folds, which are ADP-ribose-binding modules 
that can facilitate the localization of these ARTs to sites of poly and mono(ADP-ribosyl)ation 
(Gibson BA et Kraus WL., 2012). 
III.5. PARPs inhibitors 
     PARP-1 has been the target for design of PARP inhibitors. These have been claimed to 
have applications in the treatment of many disease including cancer, inflammations and 
retroviral infection. It must made some questions concerning to PARP-1 inhibitors before 
their use in treating of human diseases.  
     These questions are related to chemical properties of the inhibitors, specificity, including 
isoforme-selectivity. Another question concerns the fact that different diseases may require 
therapeutic PARP-1 inhibition to be either short-term or chronic. The answers to these 
questions could determine the future of disease therapy through inhibition of PARP (Woon 
EC et al., 2005). 
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     The Figure 44 shows different DNA repair pathways involving PARP inhibitor action. 
The PARP inhibition can perturb highly the HR mechanism.  
 
Figure 44: Model of PARP inhibitors action in single strand nick. PARP inhibitors and truncated PALB2 
pathway leads to error prone repair of DNA.(Metzger MJ, et al., 2013). 
 
     PARP inhibitors increased the rate of nick-induced HR. Additionally, expression of the 
PALB2 (partner and localizer of BRCA2 with synergistically function with a BRCA2) 
revealed an alternative mutagenic repair pathway for nicks. When  PARP inhibitors were 
added both DNA damages (SSBs and DSBs) are using in a common pathway NHEJ when 
PALB2 mechanism is truncated and/or.(Metzger MJ, et al., 2013).  
     The use of ABT-888 (platinum drugs for cancer therapy) associated with PARP inhibitors 
in the same treatment can increase mutation risk and cancer rate in murine model. In this 
model, it was demonstrated that pharmacological inhibition of PARP-1 led to NHEJ driven 
repair mechanisms (Southan GJ et al., 2003).  
     Recently, PARP inhibitors combined with cytotoxic chemotherapeutic agents in the 
treatment of BRCA-1/2 deficient cancers are in the clinical development. PARP inhibitors can 
be applied with other anticancer agents in clinical trials since them maybe playing anti-
inflammatory role (He YJ et al., 2013). 
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III.6. PARP in mitochondria 
     Of all ARTs only PARP-1 was detected into mitochondria in HeLa cells thanks to 
internalization by mitofilin receptor present in IMM (Rossi et al., 2009). Knockdown of 
mitofilin in HeLa cells with siRNA led to disorganization IMM and Cyt c redistribution 
linked with intrinsic apoptotic induction. Thus, mitofilin plays important functions in cristae 
remodeling and controls Cyt c release during apoptosis (Rui-Feng Yang et al., 2012). 
IV.Ѝ. DNA repair mechanisms in Drosophila  
Figure 45: Schematic representation of Drosophila melanogaster life cycle. 
http://www.flickr.com/photos/11304375@N07/2993342324/  
 
     Drosophila melanogaster genome is very well known and some genetic mutation can be 
visibly manifest as morphological changes in the adult animal as eyes color. It is easily 
cultured population of the wild, (Figure 45), has a short generation time, and also large 
number of mutant animals are readily obtainable.  
 
     The Poly(ADP-ribose) metabolism 
     In D. melanogaster, PARP gene is localized in chromosome 3 (Miwa M, et al., 1995), 
determined by in situ hybridization (Hanai S. et al., 1998) and cytology confirmed by PCR 
and finally classified as essential gene for fly development. The PARP gene consisted of six 
translatable exons and spanned more than 50 kb.  
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     There are two PARP RNAs populations in D. melanogaster, the first encodes the full 
length PARP protein (PARP-B), while the other is a truncated RNA which could encode a 
partial-length PARP protein (PARP-C), the second RNA was produced by alternative splicing 
(loss of exon 5) and the resulting protein lacks the automodification domain (Uchida M et al., 
2001). (Figure 46).  
 
Figure 46: Schematic representation of PARP isoformes in Drosophila. ParpPB (113 kDa) is encoded by the 
full transcript and ParpPC (92 kDa) by the truncated transcript.  
     Two main actors of the Poly(ADP-ribose) metabolism were shown in nucleus from 
Drosophila melanogaster cells. Boamah and collaborators showed the presence of PARP-B 
and PARG in nucleus. PARP-B is essential for fly development. Deletion or disruption of 
PARP-B protein functions disintegrates nucleolus structure (Figure 47). Thus, PARP-B 
controls nucleolar structural integrity (Boamah EK, et al., 2012).DNA repair pathways in 
Drosophila melanogaster can be associate with larval diet.  
     Recently studies show a repair reporter construct system (Preston CR., 2006) that allows 
us to induce DSBs in the germ-line cells of adult male D. melanogaster and compare the 
relative frequencies of HR, SSA, and NHEJ across the two condition groups these males bear 
gene constructs that serve as the site of DSB creation as well as a homologous repair 
template. They also carry an endonuclease construct and continuous expression of this gene 
results in DSBs being created at the same recognition site in individual germ-line cells. 
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Successful repair by each of these three different pathways leaves behind a unique repair 
product whose genetic signature can be traced in the progeny of the males. Unfortunately, 
BER system was not studied in order to demonstrate glycosylases actions after oxidative 
DNA damages. 
Figure 47: A–B: PARP-B protein localizes to nucleoli in all Drosophila tissues, including polytene 
chromosomes of larval salivary glands (A) and diploid nuclei of larval brain (B). The dissected larval salivary 
glands and brains expressing PARP1-DsRed (red) were stained with the DNA binding dye Draq5 (green). 
Positions of nucleoli are indicated with arrows. SG – larval salivary gland; BR – larval brain. C–D. PARP-B 
deletion displaces nucleoli protein as detected by nucleoli-specific antibody AJ1 (red). AJ1 detects nucleoli in 
every cell of Drosophila mid-intestine in wild-type second-instar larvae (C), but only in a few cells in ParpCH1 
mutants (D). DNA is detected with OliGreen dye (green). E–H. Deletion or disruption of PARP-B protein 
functions disintegrates nucleolus structure. Salivary glands from wild-type (E), ParpRNAi expressing (F), 
hypomorphic Parp mutant, ParpC03256 (G), and overexpressing antagonist of PARP-B, PARG (H) 3rd instar 
larvae were stained for the nucleolar specific protein Fibrillarin (red) (Boamah EK et al., 2012). 
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THESIS PROJECT 
     Previous experiences of my training team concerning DNA repair (Morel., 2008) and 
aging (Dubessay P., 2007) in Drosophila melanogaster as biological model led that my thesis 
project was focused on three main aspects of mtDNA repair. 
a) Analysis of key BER enzymes activities during aging. 
     ROS production is strongly correlated with aging. Drosophila mitochondria function is 
very similar to mammalian mitochondria thus experimental Drosophila model for biochemical 
studies can be associate related to aging (Sanz A, Stefanatos R, McIlroy G., 2010).  
     This analysis will be performed through a comprehensive approach using a microarray 
carrying various oligonucleotides of DNA modified. Each DNA modification represents a 
specific DNA damage what is susceptible of glycosylases and endonuclease enzymatic action. 
The biological potential of certains enzymes BER can be quantify during aging in Drosophila 
melanogaster model. 
b) Is PARP protein involved in mtDNA repair in Drosophila melanogaster? 
     Miwa and collaborators showed the PARP expression in Drosophila melanogaster, they 
also identified the PARP-B and PARP-C isoforms demonstrating that only PARP-B has 
catalytic action (Miwa prénom et al., 1999). Ten years after PARP-1 was identified in human 
mitochondria by Rossi and al 2009. 
   ¨in silico¨ analysis shows 61% homologies between orthologs proteins. All these points put 
together with the essential role in DNA repair processes stimulated the questioning about 
PARP involvement into mtDNA repair in fly model. This question will be sequentially 
answered: 
Is PARP-B present in Drosophila mitochondria? 
Is PARP-B isoform involved in mtDNA repair? 
Does PARP-B isoforms expression profile change under oxidative stress conditions? 
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c) How is PARP regulated at a transcriptional level in different Drosophila mutants 
for key BER enzymes? 
     PARP-1 is involved in BER mechanism at different levels with different roles. It interacts 
with protein such as OGG1 (Hooten N, et al., 2011) in first steps of BER as well with DNA 
strands after abasic site excision by endonuclease in order to stabilize DNA damage. This 
question will be answered with a RT-QPCR analysis of mRNA PARP accumulation in 
various mutants such as ogg1-/-, rrp1-/-, xrcc1-/- and ogg1-/xrcc1-. 
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MATERIAL AND METHODS  
All chemicals were obtained from Sigma unless otherwise stated 
 
I.Ѝ.Animals 
     All flies used in this study were from D. melanogaster strain either generated in our 
laboratory (Wild type flies) or obtained from Bloomington Stock collections for mutants 
(University of Indiana, USA), (Table 5).  
     They were reared on axenic medium (Alziari S, et al., 1985) at 19°C. 
D. melanogaster Phenotype (eyes color ) Origin 
Wild Type (WT) white Laboratory 
ogg1-     (FlyBase code) 19122 orange Bloomington Stock 
rrp1-       (FlyBase code)  10213 orange Bloomington Stock 
xrcc1-     (FlyBase code) 18682 orange Bloomington Stock 
ogg1-/xrcc1- red This study 
Table 5: Different D. melanogaster strains used in this study. Number beside the mutant name indicates the 
FlyBase code. 
 
     Only ogg1-/xrcc1- mutant strain was generated using classical genetic crossings illustrated 
in Figure 48. 
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Figure 48: Representation of double mutant production strategy. The pBac DNA insertion ogg1[f08013] and 
xrcc1[f03685] were represented in red color. Eyes colors were indicated with thin arrows in all fruitflies. 
 
II.Ѝ.Sub-cellular fractionation 
     II.1. Sub-cellular fractions purification (nucleus and mitochondria) 
 
     Mitochondria were prepared according to protocols previously described in Alziari and 
collaborators briefly (Alziari S, et al., 1985), 300-400 males fruitflies were used for each 
mitochondria preparation. They were immobilized on ice and ground into small aliquots (50 
individuals) with a mortar and pestle in 2 mL of isolation buffer. The resulting suspension 
was filtered on Sefar Nitex membrane, and centrifuged (240g, 10 min.). The pellet was kept 
for further nuclear purification and the supernatant (lysate) was centrifuged (3000g, 10 min). 
The resulting pellet was suspended in 2 mL of isolation buffer, and centrifuged twice for 10 
min at 7000g. The final pellet was the “crude mitochondrial fraction”. 
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     The following steps were conducted according to Alziari and collaborators Preformed 
Percoll gradient was prepared by a 55,000g centrifugation of 55% Percoll solution for 1 h. 
The crude mitochondrial fraction was gently layered onto this preformed Percoll gradient. 
After further centrifugation (55,000g, 1 h), purified mitochondria could be detected as 
discrete bands in the middle part of the gradient. Bands were collected from the tube with a 
needle, pooled, and diluted volume to volume with isolation buffer. This solution was 
centrifuged twice for 10 min at 7000g. The resulting pellet was the “pure mitochondrial 
fraction”. 
     The next step for mitochondria purification was mitoplast preparation. Pure mitochondrial 
fraction was incubated for 15 min at 4 °C with 0.1 mg of digitonin per mg protein with 
frequent stirring. After dilution with two volumes of isolation buffer, the solution was 
centrifuged (10,000g, 5 min). The pellet was washed twice (10,000g, 5 min), and finally 
suspended in 200-400 L of isolation buffer. This fraction was “purified mitoplasts”. 
     The first pellet obtained after the first centrifugation of the crushed fruitfly suspension was 
suspended in isolation buffer, filtered on Sefar Nitex membrane, and centrifuged for 10 min at 
240g. The pellet was suspended in 2 mL of isolation buffer and centrifuged for 10 min at 
650g, giving the “crude nuclear fraction”. 
     The purified nuclear fraction was obtained using a subsequent purification step on a 
sucrose cushion. Briefly, a 2 mL solution of 2M sucrose was prepared in 3.5 mM MgCl2, 3 
mM DTT and loaded onto a polyallomer tube. The crude nuclear fraction was gently layered 
on the sucrose cushion top, and centrifuged at 124,000g for 1 h. The pellet was washed twice 
at 10,000g for 10 min in 1 mL of isolation buffer, and suspended in 500 L. 
     II.2. Mitochondrial fractions validation  
          II.2.1. Western blot analysis 
     Equivalent protein amounts (15 g) from mitochondrial or nuclear fractions were run on 
10% or 15% SDS-PAGE, and blotted on nitrocellulose membrane (GeHealthcare). Western 
blot analyses were performed with the following dilutions using antibodies raised against 
lamin 1:750 (DSBH), histone H3 1:2,000, Rieske 1:13,500 (gift from Dr C. Godinot, Lyon), 
PDH 1:2,000 (Mitosciences). Various incubations and detection were as previously described 
by Dubessay and collaborators (Dubessay P, et al., 2007). 
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          II.2.2. Enzyme assays 
     All the enzymatic measurements were made with a heat-controlled spectrophotometer 
(Shimadzu) at 28 °C. Both activities were assayed using a previously described protocol. 
 a. Cytochrome oxidase assay 
     The activity of Cyt c oxidase was measured as the decrease in absorbance due to the 
oxidation of Cyt c at 550 nm (= 18,500 M-1. cm-1). The addition of 10 g of protein from 
mitochondrial or nuclear fractions to the reaction mixture (50 mM KH2 PO4, mM EDTA, 100 M cytochrome c, pH 7.4) initiated the reaction. 
 b. Citrate synthase assay  
     Citrate synthase activity was measured as the increase in absorbance due to the reduction 
of 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) at 412 nm, coupled to the reduction of 
coenzyme A by citrate synthase in the presence of oxaloacetate (= 13,600 M-1. cm-1 ). The 
assay was performed with 10 g of proteins added to the reaction mixture (100 mM Tris HCl, 
pH 8, 2.5 mM EDTA, 37 M acetyl-CoA, 75 M DTNB, 320 M oxaloacetate). 
 
III.ЍComprehensive BER repair analysis through microarray technology  
     The excision reactions were conducted using the modified oligonucleotide arrays already 
described elsewhere (Pons B et al., 2010). 
     Briefly, each well of a 24-well slide was functionalized by a series of lesion-containing 
oligonucleotide duplexes (lesion ODNs) and a control duplex (control ODN, with no lesion). 
The duplexes were tethered to the slide surface by one end, and labeled with a Cy3 at the 
other end. All the duplexes were attached in duplicate.  
     Eight lesion substrates were present: ethenoadenine (EthA) paired with T, hypoxanthine 
(Hx) paired with T, 8oxoguanine (8oxoG) paired with C, A paired with 8oxoG, thymine 
glycol (Tg) paired with A, tetrahydrofuran (THF), as abasic site (AP site) analog, paired with 
A, uracil (U) with G and U paired with A. 
     Excision reactions were conducted with 10 g of protein per well at room temperature (23 
°C) for 1 h in 80 L of excision buffer (10 mM Hepes/KOH pH 7.8, 80 mM KCl, 1 mM 
  78 
EGTA, 0.1 mM ZnCl2, 1 mM DTT, 0.5 mg/mL BSA). The slides were subsequently rinsed at 
room temperature for 3 x 5 min with 80 L of washing buffer (PBS containing 0.2 M NaCl 
and 0.1% Tween 20). On each slide, two wells were incubated with the excision buffer only 
(control wells) to serve as a reference, arbitrarily set at a fluorescence level of 100% for the 
calculation of the excision rates (Figure 49) 
 
Figure 49: Schematic representation of glycosylase action detection on microarray. Step 1 represents 
incubation of oligonucleotides modified with biological extract; step 2 represents the glycosylase and 
endonuclease actions enzyme and the step 3 washing . Microarray analyses show in green color the glycosylase 
action dot.  
     The spot fluorescence was quantified using a GenePix 4200A scanner (Axon Instrument, 
Molecular Devices, Sunnyvale, CA, USA). Total spot fluorescence intensity was determined 
using the GenePix Pro5.1 software (Axon Instrument). 
     Each extract was tested twice. The results between replicates (four spots) were normalized 
using the NormalizeIt software as described by Millau and collaborators. A first operation 
calculated the excision rate of each of the lesion ODNs in the extract-containing wells 
compared with the lesion ODNs of the control wells. A correction was then applied that took 
into account the possible degradation of the control ODN (no lesion). Final results for each 
lesion ODN, expressed as percentage of cleavage, were calculated using the formula: (100-(1-
percentage of fluorescence of lesion ODN/percentage of fluorescence of control ODN)). 
 79 
IV. →Molecular Analysis  
     IV.1. Expression analyses 
     These analyses were performed either with S2 cells lines from Drosophila melanogaster or 
with fruitfly stock  
          IV.1.1. mRNA extraction 
     50 flies or S2 cells (106 cells) were disrupted in 1 ml TRIZOL. The total RNA was purified 
according to the manufacturer's protocol (Invitrogen). The samples were solubilised in 50 µl 
distilled water and immediately stored at -80°C.  
          IV.1.2. cDNA production 
     Reverse transcriptase reactions were made using random primers (2.5 mM) and reverse 
transcriptase enzyme RT M-MLV (1 U) (PROMEGA) at 37°C during 60 minutes. All 
Reverse transcriptase reactions were made including no-template, no-RT enzyme as controls 
of genomic DNA contamination. After cDNA amplification the PCR products were incubated 
with RNAse (4g/L) at 37°C during 30 min and quantified in Nanodrop1000 
spectrophotometer. cDNA aliquots were stored at -80°C. 
          IV.1.3. RT-q-PCR  
Figure 50: Schematic representation of the Real Time quantity PCR amplification conditions.   
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     All amplifications were made according to the manufacturer's protocol using kit MESA 
GREEN qPCR MasterMix Plus; SYBR PCR, (Eurogentec). The specific oligonucleotides are 
described in Table 6. The Rp49 gene was used as a reference and all cDNA amplifications 
were made in Mastercycler-Pros PCR machine (BioRad) at Tm 60°C and 45 cycles (Figure 
50). 
cDNA Primers Sequence 5’-3’ Tm (°C) Product 
size (pb) 
ogg1 
Forward (Exon1-
Exon2) 
GGACAGAGTTTCCGATGGC 61 
199 
Reverse (Exon2) CGCACAGGCTTACTCAAGAA 60 
rrp1 
Forward (Exon1-
Exon2) 
TTGGTTTCCTGCAGGCAG 61 
213 
Reverse Exon2 CTTTTGTTTTCCAGCCACCA 61 
xrcc1 
Forward (Exon2-
Exon3) 
GTGGCATACAGAATCCCGAT 60 
210 
Reverse  (Exon3) GCCATGGCAGGTACTTCTTC 60 
parpB/C 
Forward (Exon1-
Exon2) 
TTGCTGTCATGGTTCAATCTG 60 
198 
Reverse Exon2 TTTTTCCTAATTGTGCGCTTAT 60 
parp-B 
Forward (Exon5-
Exon6) 
GCGGATAAAAAGGAGAAATATTG 58 
199 
Reverse Exon6 CGATTGGGTACATTCGACCT 60 
parp-C 
Forward (Exon4-
Exon6) 
ACAATGATGTTTTGGTTAGATATTGG 58 
201 
Reverse Exon6 Parp-B reverse   
parg 
Forward (Exon2-
Exon3) 
GTCGATTGGTAAAGCCTGTTAAA 60 
269 
Reverse (Exon3) GAACTGGACGAGAGCGAAAC 60 
rp49 
Forward  GCTAAGCTGTCGCACAAATG 57 
190 Reverse  TCTGCATGAGCAGGACCTC 58 
Table 6: Primers used for Rt-qPCR experiments. Characteristics are as follow (Gene name, Primers names, 
Sequence, Tm and amplified product length) 
 
     IV.2. PCR prior to cloning 
     All amplifications were made at 60°C Tm during 30 cycles using Pfu polymerase 
(Promega). Amplifications were performed with specific primers (Table 7) and protocol 
presented in Figure 51.  
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Figure 51: Schematic representation of PCR amplification conditions of Parp-B, GFP-targ and (Hist)6-V5-targ 
using Pfu enzyme during 30 cycles. Denaturation at 90°C, annealing at 60°C and DNA synthesis at 72°C were 
represented in purple, green and blue colors respectively. 
 
cDNA Primers Sequence 5’-3’ Product 
size (pb) 
Parp-B 
Forward KpnI-parp 
 
ccgatatcGTGTAATATGGATATTGAATT
ACCTTATCTTG 
2982 
Resverse SmaI-parp 
 
ggCCCGGGATAAGAATACTTGAATTC
CATAC 
 
GFP 
Forward SmaI-GFP 
 
ggcccgggGGTGGTAAAGGAGAAGAAC
TTTTC 
 733 Reverse BamHI-GFP ggggatccgatatcTTACTTGTATAGTTCATC
CATGC 
 
(Hist)6-V5 Forward  GGTAAGCCTATCCCTAACCCTCTCC 
115 
Reverse 
 
TAGAAGGCACAGTCGAGG 
Table 7: Primers used for Parp-B, GFP and (Hist)6-V5 PCR amplification. Parp-B and GFP primers contained 
restriction site (small letters).  (Hist)6-V5 Tag was amplified without restriction site. 
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     IV.3. PARP-B-target construction  
Table 8:Summary of clones for PARP-B construct: clon-19 J-2 represents GFP cloned in pGEM7z(+) vector in 
SmaI/BamHI positions; clon-1 represents Parp-B cloned in clon-19 in KpnI/SmaI positions; clon-7 represent 
clon-1 inserted with targ (Hist)6-V5 PCR product in SmaI position; J2 plasmid represents Parp-B-(Hist)6-V5 
cloned in  pMT puro vector in KpnI/EV positions; C-4 plasmid represent Parp-B-GFP cloned in pMT puro 
vector in KpnI/EV position and the plasmid A-8 represents Parp-B-(Hist)6-V5 cloned in pBAD24 vector in 
HindIII (treatment with klenow)/KpnI positions.  
 
     Tables 8 and 9 show the PARP-B-target construct and vector source. All DNA digests 
were made according to the manufacturer's protocol from PROMEGA.  
     The DNA product purification was made using NucleoSpin Gel and PCR Clean-Up from 
MACHEREY NAGEL and the ligation reactions were performed with T4 ligase (2.5 U) from 
PROMEGA at 4°C overnight. 
  
DNA Enzyme for DNA digestion Cloning vector 
GFP PCR product SmaI/ BamHI pGEM7z(+) (SmaI/ BamHI) 
PARP-B PCR product KpnI/ SmaI clon-19 (KpnI/ SmaI) 
(Hist)6-V5 PCR product not clon-1 (SmaI) 
clon-7 KpnI/ PmeI pMT puro (KpnI/ EV) 
clon-1 BamHI (klenow) /KpnI pMT puro (KpnI/ EV) 
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Table 9: List of plasmids used in this study. 
Figure 52: J2 plasmid: PARP-B-V5 cloned in pMT-puro vector 
 
Plasmid 
 
Source 
 
Description 
pGEM7z(+) vector 
 
PROMEGA 
 
annexes 1 
pMT puro 
 
PROMEGA 
 
annexes 2 
pBAD24 
 
Gift from Dr. MARTINEZ E, CNRS Paris 
 
annexes 3 
J2 plasmid 
 
In this study 
 
Figure 52 
C4 plasmid 
 
In this study 
 
Figure 53 
A8 plasmid 
 
In this study 
 
Figure 54 
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Figure 53: C4 plasmid: PARP-B-GFP cloned in pMT-puro vector 
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Figure 54: A8 plasmid: PARP-B-V5 cloned in pBAD24 vector 
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     IV.4. DNA electrophoresis  
     The gels were made with different agarose percentage such as 0.8, 1.0 and 2.0%. The 
agarose was prepared in TAE1X buffer (4 mM Tris, 1 mM EDTA). Ethidium bromide was 
added 1 drop (50mg/ml) per 50 ml of gel solution at 40°C. Electrophoreses were performed in 
TAE1X buffer and run at constant voltage (110V).    
     IV.5. Bacteria transformation  
          IV.5.1. Competent cells preparation 
     Competent cells were prepared according to protocol used in our laboratory. A single fresh 
colony E. coli DH5was inoculated into 3 mL of LB broth and cultured 6 hours at 37°C. 
Then the LB broth volume was increased to 200 mL and growth was carried out overnight at 
37 C and 200 cycles/min in a rotary shaker. Next, 500 L of the culture was transferred into 
50 mL of LB broth and incubated under the same conditions until culture OD600 reaches 0.3-
0.4. Growth was stopped by transfer into a 50-mL polypropylene tube stored at 0 C during 
10 min. The tube was centrifuged at 1,700 g for 15 min at 4 C. Pellet was resuspended in 10 
mL of filter-sterilized ice-cold 0.1 M CaCl2 and stored for 5 min on ice. Then suspension was 
centrifugated at 1,700 g for 15 minutes at 4 C. After discarding the supernatant the tube was 
inverted for 1 min to allow the last traces of media to drain away. Finally cell pellet was 
resuspended in 2 mL of filter-sterilized ice-cold 0.1 M CaCl2 and store for 2-3 hours on ice. 
The total volume was divided into 200 L of competent E. coli DH5  suspension in sterile 
microcentrifuge tubes and used immediately. Alternatively cells were stored at –80 C. 
          IV.5.2. Transformation 
     DNA plasmid (80-100ng) was added to competent cells kept on ice-cold and incubated for 
1 hour. A 1 min heat shock (42°C) was performed, followed by 2 min on ice. LB medium 
without ampicillin (500 L) were added and bacteria were incubated at 37°C with 200 
cycles/min in a rotary shaker during 45 min. Bacteria were plated on agar containing 100 g/mL ampicillin. 
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          IV.5.3. Cloning control 
     Several clones were selected and numbered. Each of them was split into two tubes. One 
was inoculated into an empty PCR tubes and PCR mix was added see above). PCR was 
performed (30 cycles, Tm 60 °C, 3 min at 72 °C, goTaqPol(0.25U)) with specific primers. 
The other half of the clone was inoculated in 1.5 ml of LB (ampicillin 100ug/ml) incubated at 
37°C. Plasmid purification was carried out on positive clones using NucleoBond XtraMidi kit 
(MACHEREY NAGEL). Each plasmid was tested by restriction digests on 1 g DNA. Clones 
were subsequently sequenced (MWG-Biotech, Germany). All sequences were analyzed by 
Codon Code Aligner 4.2.4 program (CodonCode Corporation). 
V.Ѝ In silico analyses 
          V.1. Mitochondrial targeting analysis  
Two softwares (Figure 55) were used such as: PSORTII, (http://psort.hgc.jp/form2.html) 
focused in subcellular localization prediction. (Horton P, Nakai K., 1997) and MitoProtII 
Computational method to predict mitochondrially imported proteins and their targeting 
sequences (Claros MG, Vincens P., 1996). The Mitoprot software is available by: 
(http://ihg.gsf.de/ihg/mitoprot.html ) 
 
 
Figure 55:  Schematic representation of results obtained with these two softwares. 
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          V.2. Protein sequences homology  
The protein Align Sequences analysis was made using BLAST: 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2
seq&LINK_LOC=blasttab&LAST_PAGE=blastn&BLAST_INIT=blast2seq  
          V.3. Caspase cleavage sites determination 
     The caspase cleavage site determination was carried using the program PeptideCutter 
(ExPASy) http://web.expasy.org/peptide_cutter/ In natural substrates, he prediction and 
characterization of proteolytic cleavage sites can lead to understand these structural 
relationships. (Garay-Malpartida HM, et al., 2005) 
          V.4. Physico-chemical properties 
     Molecular Weight (MW) and isoelectric point (pI) were determined using the program: 
Compute pI/MW (ExPASy) http://web.expasy.org/compute_pi/  
VI.Ѝ.PARP sub-cellular localization 
          VI.1. S2 cells culture  
     According to the manufacturer's protocol (modified) S2 cells were incubated in complete 
Schneider medium (Invitogen) containing Fetal Calf Serum (10%) antibiotics (Penicillin and 
Streptomycin 1%) at 24˚C until density reaches 6 to 20 x 106 cells/mL.  
          VI.2. Cells transfection 
Cells transfection was carried out on confluent cells using Cellfectin Reagent (Invitrogen)   
     Day 1: Cell preparation: 3 mL of S2 cells (2 x 106 cells/mL) were plated in a 35 mm well 
with complete Schneider’s Drosophila Medium (SDM).  
     Day 2: Transfection: Solution A (1 µg plasmid in 100 µl of incomplete SDM) was slowly 
added to 8% Cellfectin in incomplete SDM and gently vortexed. The mix was incubated 20 
min at room temperature. It was added to S2 cell culture where SDM complete medium was 
previously replaced by incomplete one. Incubation was performed during 5 hours at 24 °C. 
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Then medium was changed to complete SDM. For stable transfected cells lines, a selection 
was performed using puromycin antibiotic (5 µg/mL) during 6 weeks.  
     Day 3: Expression of protein of interest: Cells were incubated in presence of 0.7 mM 
Cu2SO4 during 24 hours at 24°C to induce the expression of the specific protein. 
          VI.3. Validation of stable cells lines 
     All PCR conditions were shown on Table 10.  GoTaqPol (0.5 U) polymerase (Promega) 
was used with the following conditions: Tm 60°C, 72°C for 3 min, 30 cycles.  
Sample Primers Sequence 5’-3’ Product size 
(pb) 
S2 genomic DNA Fw: Parp-B TTGCTGTCATGGTTCAATCTG 2888 
 Rv: Parp-B ggCCCGGGATAAGAATACTTGAA
TTCCATAC 
 
J2 genomic DNA Fw: pMT puro CCCAGTCACGACGTTGTAAAACG 3225 
 Rv: V5 TAGAAGGCACAGTCGAGG  
C4 genomic DNA Fw: pMT puro Fw: pMT puro 3810 
 Rv: GFP ggggatccgatatcTTACTTGTATAGTTC
ATCCATGC 
 
Table 10: PARP-B-target amplification: Representation of each primers used in Parp-B, GFP and (Hist)6-V5 
PCR amplification. Parp-B and GFP primers were made with restriction site. The targ (Hist)6-V5 was amplified 
without restriction site. 
     The genomic integration of cDNA construct in S2 cells was validated by PCR experiment 
on whole genomic DNA. Briefly, 100 flies were lysed in buffer (10 mM Tris HCl pH 8; 60 
mM NaCl, 10 mM EDTA) and proteinase K (20g/L) and incubated for 1 hour at 65°C. 
After addition of 0.8 M potassium acetate, the suspension was incubated for 15 min at 4°C, 
and then centrifuged (12000 g, 15 min) at room temperature.  
     Upper phase was kept and treated by RNAse (4g/L) at 37°C during 30 min. A volume 
of phenol/chloroforme (24/1) was added the solution and it was thoroughly mixed and 
centrifuged at 4°C, (12000 g, 15 min). The upper phase containing DNA was precipitated for 
1 hour with isopropanol at -20°C. The resulting DNA was washed with 70% ethanol, 
  90 
centrifuged at 4°C, (12000 g, 15 min) and finally diluted in sterile water. DNA quantification 
was in Nanodrop 1000 spectrophotometer. The aliquots were stored at -80°C.  
 
VI.4.
 
Stress conditions 
     VI.4.1. Copper stress  
     In order to induce the similar cellular stress that in protein induction mechanism, S2 cells 
were incubated with Cu2SO4 (0.7mM) during 24 hours. 
     VI.4.2. Oxidative stress 
     In order to induce a cellular stress and to promote DNA alterations, oxidative stress 
conditions were created using various [H2O2] (Table 11).  
     VI.4.3. Copper /oxidative stress 
     The stress combination was performed as follow. Cells were incubated during 24h with 
0.7mM CuSO4 then 40 mM H2O2 was added during 30 min. 
 
 
H2O2 final concentration (mM) 
 
Incubation time at 24°C (min) 
  5 5, 15 and 30 
20 5, 15 and 30 
40 5, 15 and 30 
Table 11:  Incubation conditions for oxidative stress induction in S2 cells using different H2O2  concentrations. 
 
VII.Ѝ.Microscopy 
    Forty picomoles of Mitotracker CMXRos (Molecular Probes) were added to 5 ml of S2 
cells suspension (collected at confluency) and incubated for 30 min at 24°C. The 
fluorochrome was eliminated by warm PBS 1X (24°C) with 3 quick washes.  
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     Cells fixation was performed using paraformaldehyde (PFA) 4% at 4°C during 30 min. 50 l of cells lines (GFP tagged) were directly layered with coverslip.  
     Triton100X (0.2%) was added to J2 line on slides. Protein detection was made using 
different primaries antibodies such as anti-V5 or anti-PARP (Santa Cruz). Both were diluted 
1/500 and 1/200 respectively and incubated for 1 hours at room temperature and washed with 
PBS1X, 3 times. After BSA (3%) blocking during 30 min at room temperature, 3 other 
washes with PBS1X were performed.  
     Both secondary antibodies, anti-rabbit alexa488 (for anti-V5) and anti-goat alexa488 (for 
anti-PARP) were diluted 1/320 and incubated for 1 hour. Cells were observed with Axioplan-
2 microscope (Zeiss) about ten images per slide were captured using Axiovision software 
(Zeiss) at the following wavelengths: MitoTracker: the excitation Band was 550-700 nm; 
DAPI: Violet Excitation Band was 401-418nm and FITC: Blue Excitation Band was 480 - 
500nm. 
VIII.Ѝ.Proteins analyses from Drosophila   
          VIII.1. Protein extraction 
     After 24 hours induction with 0.7mM Cu2SO4, The S2 cells were washed 3 times with 
PBS1X. Washed cells were diluted in extraction buffer. Cell lysis was performed with 
ultrasound (Vibracell; BIOBLOCK SCIENTIFIC) on ice with 15 cycles of 30 sec pulse and 1 
min.  
          VIII.2. Electrophoresis and blotting 
     Laemmli 1X (10% glycerol, 5% β-mercaptoethanol, 1% SDS, 0.02% bromophenol blue) 
was added to 20 g protein as determined by Bradford assay (BioRad) and heated at 95°C 
during 5 min. Proteins samples run was made in 10% SDS-PAGE (Table 12) at constant 
voltage (80V) during 3 hours. 
     Protein staining was directly performed in gel using 0.1% Coomassie Brilliant Blue 
(triphenylmethane) solution. 
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     Protein blotting was performed after SDS-PAGE on nitrocellulose blotting membrane 
(Millipore) at 200mA during 1 hour. Proteins on membrane were stained with 2% ponceau 
red. 
Gels 
            Running gel 10%             Stacking gel 3.2% 
0.375M Tris HCl pH 8.8 0.124M Tris HCl pH 6.8 
Acrylamide 10% (19/1) 3.2% Acrylamide (19/1) 
0.1% SDS  0.1% SDS  
0.05% ammonium persulfate  0.025% ammonium persulfate  
0.5% TEMED  0.10% TEMED  
Table 12:  Gels composition. 
 
          VIII.3. Parp-B protein detection  
     This was made using anti-V5 (PROMEGA) and anti-PARP (Santa Cruz) antibodies diluted 
at 1/200 and the respectively secondary antibodies anti-rabbit and anti-goat both diluted 
1/10000. Parp-B-Hist6 detection was made according to manufacturer's protocol using anti-
Hist6 diluted 1/20000 and anti-mouse diluted 1/10000 both antibodies.  
     Incubation times were: 2 hours for primary antibodies and 1 hour for secondary antibodies 
and all incubations were made at room temperature. LuminataTM crescendo kit (Millipore) 
was used as a substrate for peroxidase labeled-antibodies.  
          VIII.4. Mass spectrometry 
     According to Dr. BONHOMME protocol (personal communication), bands were excised 
from gel using cutting blade and forceps. Each band cut were about into 1 x 1 mm pieces and 
place in 1.5mL LoBind tube (Eppendorf). All reagents were HPLC grade. The gel pieces were 
rinsed with 300μL water for 15 min at room temperature on shaker. Acetonitrile (300μL) 
was added and washed for 15 min at room temperature on shaker.  
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     Supernatant was discarded. Gel pieces were washed with 100mM ammonium bicarbonate 
(300μL) for 15 min at room temperature on shaker. The supernatant was discarded. One 
hundred millimolar ammonium bicarbonate in 50% acetonitrile (300μL) was added and 
incubated at for 15 min at room temperature on shaker, supernatant was discarded and 
100μL  acetonitrile was added to the pellet for 5 min at room temperature on shaker. The 
supernatant was discarded.  
 
     The gel pieces were dried in a Speedvac for 5 min. Ten millimolar DTT (50μL) was 
added and incubated for 1 hour at 60°C. Supernatant was discarded. 50μL were added to  
50mM IAA and incubated for 30 min in dark at room temperature. Supernatant was 
discarded. Washing gel pieces were with 300μL 100mM Ammonium Bicarbonate for 15 min 
at room temperature on shaker. Supernatant was discarded. Washing gel pieces were with 
300μL 20mM Ammonium Bicarbonate in 50% Acetonitrile for 15 min at room temperature 
on shaker. Supernatant was discarded. It was adding 100μL HPLC Acetonitrile for 5 min at 
room temperature on shaker. Supernatant was discarded. Drying of gel pieces was in a 
Speedvac for 5 min. It was adding 20μL of Trypsin solution and incubated for 1 hour at 
room temperature.  
 
     Finally, enough Ammonium Bicarbonate at 40mM was added in 10% Acetonitrile to 
completely cover the gel pieces and incubate overnight at 37°C. It was added 150μL HPLC 
water to pieces for 10 minutes at room temperature on shaker. Removed supernatant and 
placed in a 0.5mL LoBind tube (Eppendorf). It was extract the gel pieces twice with 50μL of 
50% Acetonitrile/5% TFA for 60 min each time at room temperature. It was pooled all 
extracts and dried in a Speedvac.  
 
     The purification and concentration of peptides for in silico analysis were carried out using 
ZipTips (Tiss A et al., 2007). 
     The mass spectrometry was performed on the local Metabolomics platform facility (INRA, 
Theix Clermont) 
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IX. Recombinant protein production  
     IX.1. Protein expression 
     E. coli DH5  were transfected with plasmid A8 (pBAD24-PARP-B(Hist)6). According to 
Karin Andersson protocol’s, (Amersham Pharmacia Biotech, Uppsala, Sweden) a single fresh 
colony A8 was inoculated into LB ampicillin (100ng/ml) and cultured overnight at 37 C with 
200 cycles/minutes in a rotary shaker. Next, 500 ȣL of the culture was transferred into 50 ml 
of LB broth and it was incubated at the same conditions. When culture OD600 reached 0.5-0.6, 
expression induction was performed using L-Arabinose (with various concentrations ranging 
from 0.002% to 0.02%) during 3 hours. Bacteria were centrifuged at 1,700 g for 15 min at 4 C and the cell pellets was recovered.  
     The pellets were resuspended in 10 ml of appropriate buffer (0.16 M phosphate buffer 4 M 
NaCl, 25 mM imidazole pH 7.4). Bacterial lysis was performed at ice-cold using ultrasound 
ten times 0.5 minutes pulses. Centrifugation at 1,700 g for 15 minutes at 4 C. Recombinant 
protein was purified on a 0.2 m filter (Millipore). 
 
     IX.2. Protein purification 
     The poly-histidine tagged recombinant protein was purified manually using a column 
HisTrap Chelating, 1mL (amersham pharmacia biotech). Firstly the column was equilibrated 
with 3 volume of binding buffer (0.16 M phosphate buffer, 4 M NaCl, 25 mM Imidazole pH 
7.4),  
     The E.coli extracts (10mL) was charged into the column and was washed with 10 ml of 
binding buffer and subsequently a second wash with 10 mL of biding buffer containing 
100mM Imidazole.  
     The protein was recovered with 1mL of eluting buffer (0.16 M phosphate buffer, 4 M 
NaCl 250 mM Imidazole pH 7.4). The first mL collected corresponds to wash buffer that 
remained in column. Two fractions about 500 ȣL were collected and stored at -80C.  
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RESULTS 
I.Ѝ Global  analysis  of  BER  system  in  Drosophila  melanogaster 
     I.1. BER  activities 
          I.1.1. Validation  of  mitochondrial  fractions 
               I.1.1.1. Purity analysis 
     As a first step prior to any repair measurement in mitochondria, we sought to obtain 
purified functional mitochondrial fractions with no contaminants from cytosol or nuclear 
compartments, in order to ensure that tested repair activities came solely from the expected 
compartment. 
     Mitochondrial and nuclear purity was estimated using Western blot analyses with specific 
antibodies: anti-PDH (mitochondrial matrix), anti-Rieske (mitochondrial inner membrane, 
component of the respiratory complex III), anti-lamin (Dm0, nuclear envelope), and anti-
histone H3 (nucleoplasm). 
     The crude mitochondrial fraction obtained by differential centrifugation showed, by 
Western blot analysis, a persistency of nuclear proteins such as lamin and histone H3, 
suggesting a partial nuclear contamination of this fraction, independent of fruitfly age (Figure 
56, lane CM). The incubation of these fractions with low digitonin concentration in order to 
eliminate mitochondria outer membrane did not get rid of these contaminations (data not 
shown).  
     A subsequent purification step from crude mitochondrial fractions on Percoll gradient 
(Figure 56, lanes PM) not only preserved the fraction integrity as shown by the presence of 
mitochondrial matrix protein PDH, but was also sufficient to eliminate residual traces of 
nuclear components. An additional treatment of these fractions with digitonin removed all 
residual contaminants (Figure 56, lanes Mpl). All the results confirmed that these fractions 
(purified mitochondria (PM) and mitoplasts (Mpl)) could be further analyzed for 
mitochondrial BER activity assays. 
     In parallel, crude nuclear fractions were prepared and analyzed by Western blot. As 
observed for mitochondria, these fractions were still contaminated with other compartment 
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proteins (Figure 56, lanes CN) such as PDH and Rieske. Another purification step using a 
sucrose cushion led to the almost complete disappearance of mitochondrial contaminants in 
purified nuclear fraction (Figure 56, lanes PN). These results prove that BER activities 
measured in the purified nuclear fractions were exclusively of nuclear origin. 
Figure 56: Western blot analyses of various sub-cellular fractions. Mitochondrial (A) and nuclear (B) protein 
fractions were analyzed: 15 mg of crude mitochondrial fraction (CM), Percoll gradient purified mitochondria 
(PM) and purified mitoplast fraction (Mpl) from young (1 week) and old (8 weeks) fruitflies were separated by 
SDS PAGE, transferred on membrane and analyzed by Western blot. Antibodies directed against complex III 
Rieske subunit (mitochondrial component) or against lamin and histone H3 (nuclear components) were used. 
 
               I.1.1.2. Functionality analysis 
Figure 57: Enzymatic activity measurements in various sub-cellular fractions. Cytochrome oxidase (A) and 
citrate synthase (B) activities were measured in various subcellular compartments: purified nuclear fraction 
(PN), crude mitochondrial fraction (CM) and purified mitoplast fraction (Mpl). Fractions from young (black) 
and old (gray) fruitflies were analyzed. Error bars represent the SD of independent experiments (n = 12, 
Student’s test: ** p < 0.01). 
     After determining the fractions purity, mitochondrial functionality was assessed using 
enzyme assays. Two enzyme activities were chosen: cytochrome oxidase (complex IV of the 
respiratory chain, Figure 57A), and citrate synthase (a mitochondrial matrix protein from the 
Krebs cycle, Figure 57B).Change (2.6-fold) for citrate synthase activity between crude 
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mitochondria and mitoplasts was significant (p < 0.05). By contrast, the increase observed for 
cytochrome oxidase between these two fractions (1.34-fold) with young fruitflies was not 
significant. All these results confirmed that mitochondrial fractions were functional for further 
studies. 
               I.1.2. Nuclear BER activities  
     Validation of microarray approach on Drosophila model     Specific BER glycosylase and 
endonuclease activities were measured using modified oligonucleotide microarrays designed 
for the determination of BER capacities in nuclear extracts. As a first step, nuclear BER 
activities were analyzed to confirm the efficiency of the microarray with fruitfly extracts.  
     Most of the eight DNA lesions present on the microarray were detected and excised by 
these extracts, suggesting the presence of the corresponding specific 
glycosylases/endonuclease in these samples. However, four main activities were observed in 
nuclear extracts from young individuals (Figure 58A).  
     The endonuclease activity that cleaved THF paired with A with approximately 60% 
excision rate was predominant. The cleavage rate of Hx, U and A, paired respectively with T, 
G and 8oxoG was also high (more than 25% excision). Other activities were lower than 10%.  
     During aging, only Hx-T and A-8oxoG were significantly decreased (68%, p < 0.05). 
Hence, as also for various cell models, these modified oligonucleotide microarrays were 
efficient in determining BER activities in nuclear extracts from Drosophila melanogaster. 
               I.1.3. Mitochondrial BER activities 
     Mitochondrial fractions, both crude mitochondria (Figure 66B) and pure mitoplasts 
(Figure 66C) from young individuals, were tested in the same conditions. In crude 
mitochondria samples, four major excision activities were observed with the following 
efficiency rate order: THF-A (80% excision rate) > U-G>, Tg-A> Eth-A.Other activities were 
not detectable (Hx-T; 8oxoG-C; A-8oxoG and U-A). Pure mitoplast fraction was analyzed to 
compare with the crude mitochondria preparation. The global activity profile was quite 
similar to the one obtained with crude mitochondrial fraction, but provided additional 
information. The main changes were observed with the excision percentages, which were 
globally higher in mitoplasts than in crude mitochondria. In particular, excision of U-A was 
effective in mitoplast fraction whereas it was almost undetectable in crude mitochondria. 
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     An interesting observation was made regarding the effect of aging (Figures 58B and 58C). 
Two tendencies observed with crude mitochondria were significant with the mitoplasts. A 
marked increase (2.4-fold, p < 0.05) of U-G excision was detected, whereas other activities 
declined. Aging-associated decrease was significant for THF (-18%).  
 
Figure 58: Cleavage rate measurements using lesion-containing oligonucleotide microarrays. The cleavage rate 
represents the percentage of loss fluorescence at each lesion spot after incubation with purified nuclear 
fractions (A), crude mitochondrial fraction  (B) and purified mitoplasts (C). The different lesion substrates are 
indicated: ethenoadenine paired with T (Eth-A), hypoxanthine paired with T (Hx-T), uracil paired with G (U-G), 
tetrahydrofuran paired with A (THF-A), 8oxoguanine paired with C (8oxoG-C), A paired with 8oxoguanine (A-
8oxoG), thymine glycol paired with A (Tg-A), uracil paired with A (U-A). Fractions from young (white) and old 
(black) fruitflies were analyzed. (n = 3-7, Student’s test: * p < 0.05). Error bars represent the SD of independent 
experiments. 
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     Even though endonuclease activity was high in both nuclear and mitochondrial extracts, 
these results show that BER activities in mitochondria were different from their nuclear 
counterpart, and that aging interferes with these capacities.  
     Most of the observed activities were a consequence of the presence of specific 
mitochondrial isoforms from various BER glycosylases. In silico analyses were performed to 
investigate the ability of candidates proteins to be involved in such activities. These proteins 
were described in several organisms mitochondria but were less known for Drosophila model.  
 
II.Ѝ Mitochondrial addressing predictions   
     Two different computer programs were used. In a first step, PsortII was chosen for its 
ability to give a mitochondrial addressing prediction, but also predictions for other 
compartments locations. MitoProtII was used as complement software to reinforce the 
previous results.  
     A group of 8 proteins from Drosophila and one from human was investigated. On one 
hand, molecules directly involved in BER process were tested such as one glycosylase (Ogg1-
PA), two isoforms of a specific endonuclease (Rrp1 PA and PB), the Ligase III partner 
(XRCC1-PA), two isoforms of poly-(ADP-ribose) polymerase (Parp-PB and PC), poly-(ADP-
ribose) glycohydrolase (Parg-PB), and on the other hand a known mitochondrial protein : 
isocitrate dehydrogenase (idh-PC). 
     As shown in Table13, two populations of proteins were present. A first group with a high 
prediction index for nuclear addressing (≥ 75 %) including Rrp1-PA and PB, XRCC1-PA, 
PARP-PB and PC was observed and a second group (one protein) with a high prediction 
index for mitochondria (≥75%). Between, these two groups, some proteins were analyzed 
without any strong predictive index for any locations.  
     However, we must keep in mind that this predictive approach is based on the presence of 
consensus sequences in proteins such as NLS (nucleus targeting) or MTS (mitochondria 
targeting) and that many proteins have been shown to be present in mitochondria without any 
detectable MTS region. 
     This first analysis suggested that some of these proteins could be present in Drosophila 
mitochondria. The Table 13 shows PsortII and MitoProtII addressing prediction of certain 
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protein such as: ogg1, rrp1, xrcc1, parp-B, parp-C, parg-B, Idh-C and RpL32-A from 
Drosophila melanogaster and parp-1 from human. Red color represents very high nuclear 
addressing prediction and green color very high mitochondrial addressing prediction. ND: non 
determined. 
Name Addressing prediction 
  Nuclear Mitochondrial 
FlayBase 
code PsortII MitoProtII 
Ogg1-PA 35 22 44 
Rrp1-PA 92 ND 19 
Rrp1-PB 100 ND 27 
XRCC1- 78 9 19 
Parp-PB   78 ND 5 
Parp-PC 83 ND 2 
Parg-PB   61 4 1 
Idh-PC ND 61 90 
Human 
Parp1 
67 4 8 
Table 13: Mitochondrial addressing prediction of some proteins involved in BER mechanism from Drosophila 
and human species.  
 
III.Ѝ.Base excision repair genes expression in Drosophila  
     III.1 Relative mRNA expression in wild-type context  
     Using the Flybase database (http://flybase.org/), few BER genes expression (identical to 
those illustrated in chapter II) was analyzed in young male flies (5 days old). Among the five 
candidates, Xrcc1 showed the higher level of expression, followed successively by Rrp1, then 
ParpB/C and PARG and finally Ogg1.  
     Levels of expression of the same BER candidates were evaluated in 5 days old male flies 
in order to get a representative pattern of their expression in basal conditions (Figure 58). All 
these values were estimated by RT-q-PCR using Rp49 (Ribosomal protein used as external 
control of DNA repair systems) as an internal reference. The same expression pattern than 
that obtained with Flybase data was observed In fact specific gene (glycosylase) displays a 
lower expression level than those encoding crossroads proteins such as Xrcc1 and Rrp1. 
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Figure 58: Relative mRNA expression of 5 days old male Drosophila melanogaster .from FlyBase Data and in 
this study RT-q-PCR results (n=3).  
 
     III.2. Relative mRNA expression in ogg1-  mutant flies 
     The Figure 59 shows the relative mRNA expression of ogg1, rrp1, xrcc1, parp and parg in 
ogg1-(FlyBase code 19122) compared to WT. Ogg1 is very poorly detected with value lower 
than 5%.  This residual expression is not artefactual since the mutant was obtained by an 
inserted Piggybac transposon element into the ogg1 gene, resulting into a truncated mRNA 
and a total disappearance of the protein. rrp1, xrrc1 and parg expressions remain stable 
compared to levels obtained in wild-type. However Parp expression is almost reduced by 
60%. 
     The DNA glycosylases dOgg1 and RpS3 in Drosophila S2 cells are involved in 
the repair of oxidative damage. Overexpresing of these genes in mitochondria are implicated 
in apoptosis pathways of S2 cells (Radyuk SN et al., 2006). 
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 Figure 59: Relative mRNA expression of ogg1, rrp1, xrcc1, parp and parg in ogg1- mutants flies compared to 
WT. The results are the mean ± deviation (Student’s test: *** p < 0.001). n = 3 
 
     III.3. Relative mRNA expression in Rrp1-- mutant flies 
   Figure 60: Relative mRNA expression of ogg1, rrp1, xrcc1, parp and parg in rrp1- mutants flies compared to 
WT. The results are the mean ± deviation. Student’s test: ***p<0.001, **p<0.01 ,n = 3
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     As illustrated in Figure 60, the relative mRNA expression of the six chosen genes in rrp1- 
mutants (Flybase code 10213) compared to WT was analyzed. The efficiency of the Rrp1 
knock out was validated by the lack of Rrp1 mRNA detection. Compared to results obtained 
with Ogg1-  mutant flies, all tested mRNA expressions were increased in the Rrp1- context, by 
140 to 160 % except Xrcc1 that was decreased by 60%. All these changes were highly 
significant. 
    III.4. Relative mRNA expression in Xrcc1-  mutant flies 
     XRCC1 protein is known to be an essential partner for BER processes. This protein 
presents BRCT domain essential to mediate protein interactions. PARP-1 at sites of DNA 
strand break facilitates DNA repair by recruiting through BRCT motifs interaction the 
protein, XRCC1 (Buelow B et al., 2009 ;  El-Khamisy SF. et al., 2003). Also, Ligase 3 is 
recruited through BRCT motifs of XRCC1 making strong interactions in the C-termini of 
these polypeptides during the ligation of newly synthesized strand during the last step of BER 
processes (Tomkinson AE, Mackey ZB.,1998). 
 
Figure 61: Relative mRNA expression of ogg1, rrp1, xrcc1, parp and parg in Xrcc1- mutants flies compared to 
WT The results are the mean ± deviation. Student’s test:  ***p<0.001, n= 3. 
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     Only Parg expression was increased by 130% compared to WT, and all other tested 
mRNA showed dramatic decreases in their expression levels ranging from 40% (Rrp1) to 
almost 70% (Parp B/C). (Figure 61)     
     In order to evaluate interactions between first (glycosylase) and last steps (Xrcc1) 
processes in the BER pathway and their impact on other partners’ regulation, a double 
knockout was produced. 
     III.5. ogg1-/xrcc1- double knockout generation 
     Double knockout (ogg1-/xrcc1-) flies were made using as a selection marker the red color 
eye intensity depending on the PiggyBac copies number present in the genome. Fruitfly 
parents had pale red color due to Piggybac insertion in a white phenotype background (w1118 
PBac{WH}Ogg1f08013 or w[1118] PBac{w[+mC]=WH}XRCC1[f03685]. Based on eyes 
color, 3% of total third generation flies were homozygous for ogg1-/xrcc1- mutations  
     III.6. Relative mRNA expression in ogg1-/xrcc1- double knockout flies 
 
Figure 62: Relative mRNA expression of ogg1, rrp1, xrcc1, parp and parg in ogg1-/xrcc1- mutants flies 
compared to WT. The results are the mean ± deviation  Student’s test: ***p<0.001 (n = 3). 
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     The reality of the double knockout was confirmed by the lack of ogg1 and xrcc1 
expression in the tested flies (Figure 62). Interestingly, the observed expression pattern was 
quite similar to that obtained with single xrcc1 knockout strain. A strong decrease in Rrp1 and 
PARP B/C expression was detected and an increase in PARG expression (+ 145%). Such a 
behavior suggests that the lack of XRCC1 protein remains a key element in the global 
regulation process of other BER partners.  
 
IV.Ѝ.PARP AS A CANDIDATE FOR MITOCHONDRIAL DNA REPAIR IN 
DROSOPHILA?  
     IV.1 PARP isoforms relative expression  
     In Drosophila melanogaster, two different PARP isoforms have been described: PARP B 
and C. Both of them are transcribed from a single copy gene but PARP-C is a product of an 
alternative splicing process leading to the removal of exon 5 compared to PARP-B mRNA 
(Kawamura T et al., 1998). 
     Little information is known regarding either the exact roles for each of these forms or their 
eventual functional relationships. To help into the understanding of these two PARP isoforms, 
we started by analyzing the relative expression of both of them in various contexts.  
          IV.1.1 In whole Drosophila organism 
       In 5 days old wild type males (Figure 63), PARP C expression was 1.5 fold higher than 
that of PARP B. In the mean time, the expression of PARG mRNA appeared similar to that 
for PARP B. The same study was performed in rrp1-(Flybase code 10213) mutant flies. This 
mutant context was chosen due to the fact that it was the only one displaying an increase in 
PARP B/C expression. 
     Our purpose was to investigate the role of PARP B/C or its effects on other BER 
molecules in Drosophila; this is why rrp1 mutant was chosen with the PARP B/C up-
regulation in this genetic background. Interestingly, PARP-C mRNA level remained 
unchanged compared to PARP-B that was increased by 1.5 fold in mutant flies. In the case of 
PARG, the observed increase was almost by 170 %.  
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Figure 63: Relative mRNA expressions of PARP isoforms and PARG in wild type (WT) or Rrp1- mutant (Rrp1-) 
Drosophila using RT-q-PCR experiments. All values are expressed as percentages using PARG expression level 
in WT context as a reference. The results are the mean ± deviation Student’s test: ***p<0.001, **p<0.01, n = 3. 
 
          IV.1.2. In S2 cells 
     The same kind of quantification was performed in Drosophila derived cell lines: S2 cells 
in order to get information on a model that could be used further under stress conditions. 
After RT-q-PCR experiment on mRNA extracted from S2 cells in normal culture conditions, 
PARP-B and PARP-C level appeared almost identical. PARP-B/PARP-C Expression Ratio 
(ER) is about 1 (Figure 64) compared to ER about 0.7 in WT whole flies.  
     IV.2. PARP isoforms relative expression in stress conditions  
     PARP is known in several models to be a key actor during cell responses to various stresses 
playing roles in DNA repair, apoptosis, and gene transcription (Shall S. et al., 2000). 
          IV.2.1. Copper stress 
     As a first stress, copper was chosen for its ability to inhibit the repair of some oxidative 
DNA damages and to interfere with the process of poly-(ADP-ribosyl)ation (Schwerdtle T et 
al., 2007). 
 107 
 
Figure 64: Relative mRNA expressions of PARP isoforms in S2 control and S2 under cooper stress using RT-q-
PCR experiments. All values are expressed as percentages using PARP B expression level in S2 context as a 
reference The results are the mean ± deviation. Student’s test:  *p<0.05, **p<0.01, n = 3.
 
 
     In our experiment, after copper incubation (0.7 mM) during 24 hours, PARP-B mRNA 
levels were increased to 110% and PARP-C mRNA levels depleted by 20%. (Figure 64). 
PARP-B and PARP-C level appeared with ER=1.4 compared with S2 control (ER about 1) 
with very high significance.  
 
          IV.2.2. Oxidative stress 
     After 40mM H2O2 incubation during 30 min, a small increase was noticed for PARP-B and 
a 40% increase for PARP-C with high significancy. (Figure 65) PARP-B/ PARP-C was 
around 0.8 showing a slight decrease compared to ER in S2 control (approximately 1) without 
significancy. 
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Figure 65: Relative mRNA expressions of PARP isoforms in S2 control and S2 under H2O2 stress. Using RT-q-
PCR experiments. The results are the mean ± deviation. Student’s test:  *p<0.05, **p<0.01 (n = 3). 
 
          IV.2.3 Combination of copper and oxidative stress 
     Some of the detrimental effects observed with copper are mediated through oxidative 
stress generation. In the following experiment, incubation was performed with a combination 
of copper/ H2O2.  
     There is a potentiating effect of both components, illustrated by a 30% increase for PARP-
B mRNA levels and by 45% increase for PARP-C with high significance (Figure 66).  
     Nevertheless, PARP-B and PARP-C level were increased but their ER=0.9 was similar to 
that observed with S2 control (ER about 1).  
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Figure 66: Relative mRNA expressions of PARP isoforms in S2 control and S2 under copper/H2O2 stress. Using 
RT-q-PCR experiments. The results are the mean ± deviation. Student’s test:  *p<0.05, **p<0.01 (n = 3). 
 
     IV.3. PARP isoforms relative expression after stress and recovery  
     After copper/H2O2 stress followed by 30 minutes recovery in normal medium, a decrease 
was observed for PARP-B (-38%) and for PARP-C (-52%) mRNA levels. However, ER 
remains unchanged compared to S2 cells in control conditions (Figure 67). 
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Figure 67: Relative mRNA expressions of PARP isoforms in S2 control and S2 after copper/H2O2 stress S2 DNA 
repairing). The results are the mean ± deviation. Student’s test, **p<0.01 (n = 3).. 
     IV.4. Subcellular PARP localization in Drosophila melanogaster model 
    In order to get a precise view of PARP sub-cellular localization in S2 cells, specific 
constructs were generated in pMT-puro expression vectors (Annexes 2). All the obtained 
constructs are illustrated in annexes. The cloning procedure was described in the Materials 
and Methods chapter.  
          IV.4.1. Expression vectors and transfection in S2 cells 
     Two constructs were generated in pMT-puro vector. The first one encodes a PARP fusion 
protein with a V5 tag (Figure 52) at the C-terminus end of the protein and will be used for 
immunodetection in Western blot analysis but also for ¨in situ¨ localization of PARP protein. 
The second construct encodes a PARP-GFP (Figure 53) fusion protein to characterize ¨in 
situ¨ the subcellular localization of the PARP protein. Both inserts have been tested through 
enzymatic digest (annexes 6), then fully sequenced (annexes 7; annexes 8). They appear 
conform to the expected sequences. These plasmids were transfected into S2 cells. The stable 
cell lines obtained after puromicin selection were named J2 and C4 according to the name of 
transfected plasmids.  Genomic integration and mRNA expression of parp-B-V5 and parp-B-
GFP were validated by PCR amplification from genomic DNA and from total RNA 
extraction. 
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          IV.4.2. PARP subcellular localization  
               IV.4.2.1. PARP PB in basal conditions 
     The first set of experiments was performed on S2 cells in basal conditions. In Figure 68, 
using IDH-GFP construct as a positive control, a punctuated signal was observed in the 
cytosol and co-localized with Mitotracker staining, suggesting a mitochondrial localization. 
 
Figure 68: Mitochondria were identified in red color by MitoTracker detection, nucleus in blue color with 
Hoechst reactive and parp-B was identified in green color using antibody anti-parp-alexa488.  S2 untransfected 
cells were used as a negative control (Merge MitoTracker + Hoechst). The scale of picture dimension was 
represented with yellow line of 2.5 m (n = 3). 
 
     Endogenous PARP molecule was detected through the use of specificic polyclonal anti-
PARP antibodies. A strong positive punctuated signal was observed in the cytosol region. 
However, Mitotracker staining appeared more diffuse within the cell. A very faint signal 
appeared in the nuclear region in the merge part of the Figure 68.  
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     IV.4.2.2. PARP PB-V5 under copper induction 
     In a second set of experiments (Figure 69) , PARP was overexpressed in S2 cells and 
detected through the use of antibodies directed against the V5 tag of the fusion protein. 
 
Figure 69: Mitochondria were identified in red color by MitoTracker detection, nucleus in blue color with 
Hoechst  and parp-B-V5 was identified in green color using antibody alexa488 anti-V5 monoclonal antibody  S2 
untransfected cells were used as a negative control (Merge MitoTracker + Hoechst). Isocitrate dehydrogenase 
was used as a positive control for mitochondrial addressing (IDH-GFP). The yellow bar indicates 2.5 m, n = 3. 
 
     With this procedure, a peripheral MitoTracker detection was observed, but also a co-
localisation with ParPB-V5 suggesting at least, a partial mitochondrial presence of PARP. In 
the mean time, a nuclear signal was also observed for the recombinant protein.  
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     IV.4.2.3. Parp PB-GFP under copper induction 
     Using the same strategy, but with a PARP-GFP fusion protein (Figure 70), a strong 
positive GFP signal was observed in the nucleus.  However, a green but faint signal was also 
co-localized with MitoTracker in a diffuse manner in the cytosol, suggesting once again a 
potential mitochondrial localization.  
 
Figure 70: Mitochondria were identified in red color by MitoTracker detection, nucleus in blue color with 
Hoechst reactive and Parp-B-GFP was identified in green color thanks to GFP signal).  S2 untransfected cells 
were used as a negative control (Merge MitoTracker + Hoechst). Isocitrate dehydrogenase was used as a 
positive control for mitochondrial addressing (IDH-GFP). The yellow bar indicates 3.5 m. n = 3 
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IV.4.3. PARP subcellular localization under oxidative stress  
     IV.4.3.1. PARP PB  
     In order to create redox imbalance within the cells but also to induce DNA damage in the 
mean time, S2 cells were incubated with hydrogen peroxide. This experiment was performed 
to determine if oxidative stress induces PARP relocalisation within treated cells. 
     In basal S2 cells, a strong positive signal corresponding to endogenous PARP, was 
detected in the nuclear region, but also a green faint signal was observed partly co-localized 
with MitoTracker in a diffuse manner within the cytosol (Figure 71) 
 
Figure 71: Mitochondria were identified in red color by MitoTracker detection, nucleus in blue color with 
Hoechst reactive and Parp-B-GFP was identified in green color thanks to GFP signal).  S2 untransfected cells 
were used as a negative control (Merge MitoTracker + Hoechst). Isocitrate dehydrogenase was used as a 
positive control for mitochondrial addressing (IDH-GFP). The yellow bar indicates 2.5 m. (n = 3) 
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     IV.4.3.2. PARP PB-V5 
     In PARP overexpressing cells under oxidative stress exposure (Figure 72), signals were 
observed mainly in a diffuse manner within the cytosol, with partial co-localisation with 
MitoTracker probe.  
     However, no clear nuclear localization was detected. To summarize all these data, PARP 
in S2 cells was mainly localized in nuclear compartment, but also present at a lower level in 
the mitochondrial surroundings. A PARP overexpression led to a higher nuclear targeting, but 
maintained the signal in “mitochondria”. 
Figure 72: Mitochondria were identified in red color by MitoTracker detection, nucleus in blue color with 
Hoechst reactive and Parp-B-GFP was identified in green color thanks to GFP signal).  S2 untransfected cells 
were used as a negative control (Merge MitoTracker + Hoechst). Isocitrate dehydrogenase was used as a 
positive control for mitochondrial addressing (IDH-GFP). The yellow bar indicates 2.5 m. n = 3 
 
     Some PARP trafficking occurred in hydrogen peroxide exposure with a decrease in 
nuclear localization towards more diffuse cytosol localization. 
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IV.5. Sub-cellular fractionation and PARP detection  
     In order to confirm the results obtained by microscopy, another approach was performed 
using sub-cellular fractionation followed by Western-blot analysis on pure fractions.  
     Two sub-cellular fractions were tested: nuclear and mitochondrial fractions (Figure 73). 
Prior to further analyses, samples were qualified on purity basis. All mitochondrial samples 
did not show any histone protein suggesting the lack of nuclear contaminants.  
     On the opposite, nuclear samples still displayed pyruvate dehydrogenase (PDH) signals 
except for sucrose treated fractions. Using a specific PARP polyclonal antibody, two faint 
populations were observed in nuclear fractions purified (115 and 80 kDa).  
    As well, crude nuclear fraction presents very low quantity of PARP. In mitochondrial 
extracts, only low molecular weights proteins were detected at 70 and 80 kDa. These results 
were observed either with crude or purified fractions.  
     These results confirmed those obtained by ¨in situ¨ detection on mitochondrial localization 
but also showed for the first time the presence of different PARP isoforms between nuclear 
and mitochondrial compartments. 
 
Figure 73: Western blot analysis of PARP isoforms in subcellular fractions from Drosophila. (a) crude 
mitochondria, (b) crude nucleus, (c) purified mitochondria, (d) purified nucleus. The red arrows show the main 
proteins identified in mitochondrial samples and green arrow the protein visualized in nuclear sample. 
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     Using S2 recombinant cells overexpressing PARP-V5 and PARP-GFP, a new Western 
blot analysis was performed with either anti-PARP or anti-V5 antibodies.  
     As shown on Figure 74 on the left, PARP antibodies detected only one faint protein band 
around 82 kDa in S2 cells, but a strong signal at similar molecular weight was observed for 
transfected cells (PARP-V5 or GFP). Surprisingly, such a band with identical molecular 
weight was also seen with anti-V5 antibodies.  
Figure 74: Western blot analysis on S2 cells extracts using either anti-PARP (left) or anti-V5 (right) antibodies. 
(a) J2 cells (S2 cells transfected with parp-B-V5) after 0.7mM cooper incubated 24 hours, (b) J2 cells after 24h 
incubation with 0.7mM copper followed by 40mM H2O2 during 30 min, (c) C4 cells [S2 cells transfected with 
parp-B-GFP] after 0.7mM cooper incubated 24 hours, (d) S2 cells in basal conditions. The red band 
corresponds to the 70KDa band (Prestained Protein Ladder; thermo scientific) 
 
     The molecular weight (MW) of 82 KDa observed in Figure 74 is not according with any 
PARP isoforms referenced in literature but also their MW of 113 KDa and 92 KDa are not 
show until nowdays.  
IV.6. Mass spectrometry analysis  
     To confirm, the PARP nature of these various proteins, LC-MS/MS analyze was made 
where the samples selection was carried out on proteins extracted according to western blot 
results of Figure 73 from an SDS-PAGE after colloidal blue staining (Figure 75). 
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Figure 75: Protein coloration in gel using coomassie Brilliant Blue (A) Mitochondria fraction from Drosophila, 
(B) Nuclear fraction from Drosophila, (C) J2 cells extract after 24 hours incubation with 0.7mM copper . Red 
arrows show the bands (1,2,3,4,5,6,7,8) analyzed by mass spectrometry.  
     After mass spectrometry analyses, no PARP detection was observed from derived peptides 
for all the 8 samples, leading to the question of the exact nature of these bands. The samples 
analyzed were obtained without anti-proteases in extraction buffer and also any protein 
purification protocol was adapted to PARP protein.  
IV.7. Potential caspase cleavage sites in PARP  
     In normal cells, PARP behavior is modulated through various post-translational 
modifications. Among them, poly-(ADP-ribosylation) and inactivation by caspase cleavage 
are well known (Boulares AH, et al.,1999). In this chapter, we investigated Drosophila 
PARP potential to be cleaved by caspases.  
     IV.7.1. Human Parp-1  
     Human Parp1 can be cleaved by caspase 3 and_7 in position 214 and by caspase 1 in 
position 800 (from N terminus) (Figure 76). Both cleavages show identical profile of 24KDa 
and 89 KDa.  
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Figure 76: Schematic hypothetical hydrolysis of human parp1  by caspases. Red color represents caspase 3 and 
7 action and green color caspase 1 action. 
 
     IV.7.2. Recombinant protein Parp-B-V5-(Hist)6  
     Recombinant protein Parp-B-V5-(Hist)6 from drosophila can be cleaved by caspase 1 in 
positions 275, 544 and 881 (from N terminus) (Figure 77). The caspase 1 digestion profile 
gave peptides about 32 KDa, 62 KDa, 100 KDa. All of them conserved Parp epitope for the 
recognition of the protein by Santa Cruz antibody used in our experiments. Other peptides 
about 16 KDa, 55 KDa, 82 KDa conserved the anti-V5 and anti-Hist6 epitopes. 
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Figure 77: Schematic hypothetical parp-B-V5-(Hist)6 hydrolysis by caspase1. 
 
V.Ѝ.Production of recombinant PARP protein  
     The production of PARP protein was planned to have a tool to: 
 Investigate the molecular weight of a standardized PARP protein  Generate polyclonal antibodies against the whole PARP protein  
     The pBAD24 expression vector was chosen to produce PARP-B in E. coli. The construct 
used is illustrated (annexes 3) and was fully sequenced (annexes 9). It appeared conform to 
the expected PARP sequence After recombinant E. coli generation and PARP protein 
induction through L-arabinose incubation, extract was purified on His-Trap column and 
subsequent fractions were analyzed by western blot using an anti-His antibody.The Figure 78 
represents parp-B-His6 expression in E. coli. The western Blot (WB) anti-Histidine was made 
with bacterial extracts, fraction 1 and fraction 2 following purification on affinity column. In 
every sample, a single protein with a molecular weight of 85 kDa was detected.  
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Figure 78:  Western Blot on various protein fractions from bacteria overexpressing PARP protein (extract) and 
from purified fractions (fractions 1 and 2). “Wash” fraction represents the washing buffer after passage through 
the columnn; n=1 
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DISCUSION 
I.Ѝ.BER activities in mitochondria 
     Research on mtDNA repair mechanisms goes back many years, and numerous studies have 
characterized mitochondrial BER activities, especially glycosylases (Dianov GL et al., 2001 ; 
Maynard S. et al., 2010 ; Boesch P et al., 2011). The most frequent method used to identify 
and characterize these activities was based on the excision of a modified oligonucleotide 
carrying a 32P label, followed by electrophoresis and autoradiography (Gredilla R. et 
Stevnsner T.., 2012). Such an approach appeared less suitable for comparison of BER 
activities between various samples. 
     The use of a microarray technology, which has already been tested and validated (Pons B 
et al., 2010) on nuclear BER activities could constitute a powerful analytical tool for another 
subcellular compartment. However, due to the specificity and sensitivity of this technique, a 
mitochondrial purification procedure has been developed to remove any nuclear residual 
contaminant. This protocol has been validated through the detection of specific protein 
components from each compartment. It has also been chosen due to its ability to preserve 
inner mitochondrial activities. 
     We demonstrated that crude mitochondrial fractions displayed strong excision abilities for 
EthA, Tg, U (paired with G) and THF (abasic sites). However, other base modifications 
resulting from ROS oxidation were slightly or not recognized by all the mitochondrial 
fractions. Interestingly, repair activities observed with purified mitoplast fractions were both 
qualitatively and quantitatively equivalent to those measured with crude mitochondrial 
fractions, but also revealed more discrete activity (U paired with A).  
     In purified nuclear fractions, repair activities were partly different from those observed 
with mitochondria. THF and U (paired with G) were still strongly recognised as already 
described for human nuclear extracts (Prasad SC et al., 1992). Compared with mitochondria 
samples, Hx and A (paired with 8oxoG) excision activities were high, but EthA and U (paired 
with A) excision activities were less noteworthy for the mitochondrial counterparts. 
     High abasic site excision activities in nuclear or mitochondrial fractions were not 
surprising. This is in fact the middle step of the base excision repair process following 
specific glycosylase action detecting and removing modified bases. The new phosphate-
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deoxyribose bound in the resulting abasic site is then processed by apuric/apyrimidic (AP) 
endonuclease such as APE1 enzyme in mammals (Tsuchimoto D et al., 2001), which is 
active not only in nuclei, but also in mitochondria. A heterologous protein RRP1 has been 
characterized in the fruitfly in the nucleus (Sander M, et al., 1991), but its mitochondrial 
location was still unknown.  
     EthA and Tg alterations were also strongly recognised with both compartments extracts. 
They arise from ROS attack on adenine and thymine residues, which are both highly abundant 
in mtDNA particularly in the AT-rich sequence (Anderson S, et al., 1981). EthA results from 
lipid peroxidation (Speina E, et al., 2003). These etheno adducts are recognized by MPG 
(methyl-purine glycosylase) (Asaeda A et al., 2000). Neil 1, 2 and 3 glycosylases could also 
metabolize modified adenine and guanine. They have been identified in nuclei and also 
detected in mitochondria (Hu J et al., 2005 ; van Loon B et Samson LD., 2013). Tg is the 
main thymine oxidative product of ROS exposure (Dianov GL et al., 2000). 
 We found in our present study that the thymine glycol removal was quantitatively strong in 
purified mitochondria and higher than that observed in purified nuclei. Some reports have 
shown that the bifunctional glycosylase NTH1 may be responsible for Tg recognition and 
excision in mice (Karahalil B et al., 2003). 
      Uracil (paired with A), often encountered in DNA may result from incorporation of 
dUMP during replication, or be the consequence of cytosine oxidative deamination by ROS, 
resulting in U:A pairs or U:G mismatch. This DNA damage is controlled by different UNG 
glycosylases. In humans, two UNG transcripts produced by differential splicing give rise to a 
nuclear and a mitochondrial (Nilsen H et al., 1997). This glycosylase may be the only one 
able to process uracil residue in mitochondria. In fruitflies, mitochondrial location of this 
protein was still unknown. 
     In our experimental conditions, on one side no A removal paired with 8oxoG was detected 
with crude mitochondrial fractions or pure mitoplast fractions. Also, this activity was quite 
high in nuclear fractions (27% excision rate in young fruitfly nuclear fractions). In mammals, 
MYH enzyme catalyzed this activity and has been detected in both nuclear and mitochondrial 
extracts (Karahalil B et al., 2003). To our knowledge, this activity has never been described 
in fruitfly mitochondria. 
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     On the other side, 8oxoG removal was not observed in our study in mitochondrial 
compartments, despite the fact that many studies have pointed out high 8oxoG excision 
activity in mitochondria (ie from mouse liver (Sander M et al., 1991). The lack of this 
activity in mitochondria in our study could be the result of a low recognition in our conditions 
of the modified oligonucleotide attached on the microarray or a low activity in Drosophila 
mitochondria. 
     In a previous study, we described the process of aging in Drosophila melanogaster 8 
weeks after emerging (Dubessay P. et al., 2007). mtDNA mutations frequently increased 
during aging (de Souza-Pinto NC et al., 2001). This could be correlated with an increase in 
ROS production (Lee HC. et al., 2012) but also, repair mechanisms involved in DNA 
maintenance might be concerned.  
     Our results effectively showed changes in repair activities in both nuclear and 
mitochondrial fractions during aging. AP site cleavage decreased in mitochondrial fractions. 
By contrast, we observed an increase in U (paired with G) excision.  
     In nuclear fractions from old fruitflies, excision activities of A, 8oxoG, and Hx declined 
significantly. The same results were observed for U (paired with G) and 8oxo G-C, but were 
not significant. Further, no nuclear glycosylase activity was increased during aging in fruitfly. 
In mouse liver mitochondrial fractions, a high 8oxoG excision activity increase was observed 
during aging, while a decrease was noted with nuclear extracts (de Souza-Pinto NC et al., 
2001).  
     Other measured activities such as U-G glycosylase and endonuclease did not change in 
either compartment.  
     Most of the observed activities were a consequence of the presence of specific 
mitochondrial isoforms from various BER glycosylases. In silico analyses were performed to 
investigate the ability of candidates proteins to be involved in such activities. These proteins 
were described in several organisms mitochondria but it was less known for drosophila 
model.  
II.Ѝ.Mitochondrial addressing predictions   
     In silico analysis of mitochondrial addressing prediction of certain proteins from 
Drosophila melanogaster involved in BER pathway would help to understand the addressing 
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footprints in protein that maybe play a role in mtDNA repair in extending Drosophila model 
until human. According to Table 13 mitochondrial addressing studies were made using 
PSORT II and MitoProtII predictors. Certain proteins from Drosophila melanogaster such as 
OGG1, RRP1, XRCC1, PARP-B, PARP-C, PARG-B were analyzed.  
     The 100% of nuclear addressing was reported to Rrp1-PB considered as negative control 
of mitochondrial addressing. The RpL32-A (named Rp49) was the mitochondrial positive 
control with 100% of mitochondrial prediction (data not shown).  
     IDH reported 90% of mitochondrial prediction as was expected for one mitochondrial 
protein. OGG1 showed by PSORTII, a mitochondrial and nuclear addressing prediction very 
similar and by MitoProtII, a 44% mitochondrial addressing. The XRCC1, PARP-B, PARP-C, 
PARG-B mitochondrial addressing prediction was poor about 1-20% by MitoProtII analysis.  
     The human PARP1 show 8% of mitochondrial addressing. Nevertheless, Rossi and 
collaborators in 2009 showed that PARP1 was present in human mitochondria, but also that 
was related to the mitofilin receptor controlling its entry.  
     In Drosophila, mitofilin receptor (Flybase code CG6455) was discovered (2005) before 
studies of human mitofilin receptor and Parp1 mitochondrial internalization. In silico studies 
guide to possible presence of main BER actors such as OGG1 and PARP-B in Drosophila 
mitochondria: OGG1 with potential MTS and PARP-B with potential receptor in IMM.    
III.Ѝ.Base excision repair genes expression in Drosophila  
     The RT-q-PCR analysis results demonstrated that the parp mRNA expression profile was 
susceptible to regulation in the three key parts of BER pathway such as DNA base excision, 
AP site removal and DNA ligation.  
     The Figure 79 shows the possible regulation of parp mRNA through the role of OGG1, 
XRCC1 and RRP1 proteins, the two first having a positive effect and the last one a negative 
effect. We are not clear if regulatory mechanism of parp expression was carried out directly 
by OGG1, RRP1 and XRRC1 proteins or through intermediate molecules. 
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Figure 79: Schematic representation of mRNA parp regulation in BER system. The induction of mRNA parp 
expression was represented in purple and the inhibition in red. Full arrows described a positive action and 
dotted lines, an indirect action. 
     Interesting the parg expression profile (mRNA) increase 40% in mutant context rrp1-, 
xrcc1-, and ogg1-/xrcc1-; however in ogg1- context parg expression profile was similar to WT. 
This results guides that the lack of OGG1 protein did not interfere with parg mRNA 
expression, compared to RRP1 and XRCC1 proteins which led to a change for this 
expression. Role for glycosylases as regulators of other genes expression has already been 
described with knock-out models. In ogg1- mutant mice, a general metabolic perturbation was 
observed leading to changes in genes expression such as down-regulation of carnitine 
palmitoyl transferase-1, and the integral transcriptional co-activator Pgc-1Ș (Sampath H et 
al., 2012). XRCC1 deficiency was classicaly described as a severe BER deficiency. In 
fruitfly, this deficiency does not interfere with viability compared to the same deficiency in 
mouse, but in our study all tested genes expressions in fruitfly were reduced except for parg. 
IV.Ѝ.PARP isoforms relative expression  
     IV.1 It was illustrated in Drosophila rrp1- (Flybase code 10213) mRNA expression of parp 
and parg expressions about 40%. The two parp isoforms were quantified using primers 
adapted to common region among genes. In order to understand parp isoforms regulation in 
rrp1 knockout, parp mRNA variants were quantified using specific primers. The parp-B 
expression is over-expressing in 50% while parp-C expression was similar WT; also, parg 
expression was about 70%. Thus, the RRP1 protein can be implicated in parp-B and parg 
mRNA depletion (these results were discussed above). Nevertheless, western blot anti-
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PARPB/C (addressed to catalytic domain); (PARP S/L (dD-12)) and anti-parpB (addressed to 
automodification domain); (PARP L (dE-17)) would illustrate the PARP proteins with and 
without remodeling or the new isoforms. The Figure 80 below shows the different antibodies 
involved in PARP detection and relative position in PARP isoforms. The PARP-B isoform 
can be identified with sc-L (dE-17) antibody specifically.   
 
Figure 80: Schematic representation of epitopes localisation in PARP isoforms for various anti-PARP antibodies 
such as sc-L(dE-17), sc-S/L (dN-16) and sc-S/L (dD-12). 
 
      The mRNA expression ratio (ER) of ParpB/ParpC was disrupted under certain condition. 
After copper incubation ER=1.4 compared with S2 control (ER about 1) with very high 
significance. Copper is an essential but potentially toxic trace element in Drosophila 
(Balamurugan K. et al., 2007).  
     The S2 cell after copper (0.7mM) incubation of 24 hours at 24°C produces DNA damage 
because it catalyzes the generation of ROS via the Fenton reaction (Halliwell B et 
Gutteridge JM., 1990 ; Puig S et Thiele.DJ, 2002 ; Spencer WA et al., 2009).  
     Under copper stress parp-B over-expression was reported about 10%. This result shows the 
positive effect of cooper on mRNA parp-B expression. Under H2O2 incubation the parp-B 
over-expression was reported about 10% with ER similar to S2 control.  
     Curiously; the oxidative stress had a positive effect in mRNA as copper stress. Both effects 
at the same time, Cu2+ / H2O2  stress: after copper (0.7mM) incubation of 24 hours at 24°C 
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with addition of  H2O2 (40mM) incubation 30 min, evidenced that the transcript of parp-B 
increased  over-expression until 30% and ER similar to WT.  
     This results guides that copper and H2O2 are possible synergetic actions. In S2 DNA 
recovery conditions (after Cu2+ / H2O2 stress incubation followed by 30 min at 24 °C in 
normal conditions), we showed depletion in both isoformes about 40% compared to basal S2 
cells. As well, over-expression of parp is also associated in apoptotic pathway activation 
(Chaitanya GV, et al., 2010).  
     It was demonstrated in human cell with severely damaged DNA have amplified PARP-1 
activity resulting in high NAD+ consumption depleting ATP pools and this activity inevitably 
leads to passive necrotic cell death (due to prolonged ATP depletion) (Eguchi Y, Shimizu S, 
et Tsujimoto Y., 1997; Lemaire C et al., 1998). 
     In cells expressing caspase-resistant PARP-1 would be more clear the necrosis induction 
and an increased of apoptosis associate with depletion of NAD+ and consequently in ATP 
level (Herceg Z et Wang ZQ., 1999). 
     Interesting recent reports show that caspases are not only involved in apoptosis pathways. 
They are implicated in forms of cell proliferation in a Drosophila model. The caspase Dcp-1 
in Drosophila represents caspase-3 in human (Fan Y et Bergmann A., 2008 ;  Kondo S. et 
al., 2006).  
     We show in silico casp1 digestion profile of Parp-B-V5 the peptides about 16 KDa, 55 
KDa, 82 KDa, we illustrated by western blot anti-V5 the protein of 82 KDa in J2 cells.  
V.2 cells. tion profile of Parp-B-V5 Drosophila melanogaster 
     Human PARP-1 is a nuclear protein identified as an enzyme that performs central roles in 
the repair of damaged DNA, PARP-1 participates in initiating base excision repair (BER) 
(Dantzer F et al., 2000). Recently, in Human, mitochondrial localization has been shown in 
HeLa cells (Rossi et al., 2009). 
     We localized by microscopy in S2 cells Parp in nucleus and mitochondria. The oxidative 
stress increases highly the parp-B presence in nucleus and mitochondria. 
     The western blot anti-PARP results using polyclonal (PARP S/L (dN-16)) identified 
proteins about 70KDa and 82KDa in mitochondrial samples and about 113KDa in culot 
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sucrose WT sample fruitsflies. We suppose over-expression of parp-B-targ (V5 or GFP) in S2 
cells can activate casp1 in order to modulate parp level. Casp1 site cleavage in Parp-B 
produces the lost targ and a protein about 82 KDa.  
     It was demonstrated that PARP-1 over-activation can cause neuroinflammation and 
apoptosis in human cells (Turunc Bayrakdar E et al.,2013). Over-expression and over-
activity of PARP-B are involved in apoptotic cellular response in S2 cells?    
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CONCLUSIONS  
     The project performed during this PhD thesis was able to give some interesting 
informations regarding mitochondrial DNA repair in Drosophila.  
     According to the initial first question, we showed that the PARP-B isoform is present both 
in nuclear fraction. We also showed a possible new isoform about 70 kDa in mitochondria, 
that still needs to be confirmed. 
     We focused on PARP proteins under cellular stresses studying both regulation and sub-
cellular localization. The oxidative stress lets to modulate the level of each parp isoforms, but 
also the ratio of these two isoforms. Some data suggested that PARP was for a part a 
mitochondrial protein. This aspect needs to be confirmed prior going further. Finally we 
hypothesized that PARP-B over-expression may lead to caspase 1 activation with 
consequently PARP cleavage. 
     Regarding PARP regulation in BER mutants, we showed that PARP-B mRNA was 
modulated in ogg1-/-, rrp1-/-, xrcc1-/- and ogg1-/xrcc1- mutants. Except in rrp1-/- mutant, 
PARP-B mRNA decreased in every tested mutant. Molecular analyses performed in mutant 
flies contexts gave some examples of co-regulations, pointing out the functional interactions 
existing between various glycosylases or adaptator proteins (XRCC1) in the BER process. 
Such an approach needs to be further analysed, in order to investigate and understand the 
exact role each protein could have on other BER partners. 
     The last question regarding BER activities during aging was answered using a 
comprehensive approach of Base Excision Repair processes in fly mitochondria. This 
technology could be performed on fly model and was efficient to determine which BER 
activity were present, but also the level and intensity of this activity. In our study, few 
activities were high in Drosophila mitochondria and directed against THF-A, Eth-A, Tg-A 
and U-G modifications. These activities were mostly different from those observed in 
nucleus. Interestingly, aging effects were quantified on mitochondrial BER activities, raising 
the question of the role of mitochondrial BER mechanisms in aging processes.  
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PERSPECTIVES 
In short term: 
I) To understand the exact nature of the protein detected due to difference in 
molecular weight compare with PARP isoforms. It would be recommendable in 
first time to study embryos because of high level PARP expression in this state and 
after, in second time to study PARP function in the mutant casp1- 
 
We studied 
from adult young flies the mRNA profile of certain genes keys of BER system. In 
order to understand the PARP isoforms mRNA profile it would be useful to 
associate PARP isoforms mRNA profile with mRNA profile of certain keys genes 
of BER system. We propose to use a recombinant protein MTS-PARP-B caspase1 
cleavage resistant (Boulares AH et al 1999) in order to get check if the full length  
113 KDa PARP protein could be obtained in nuclear and mitochondrial samples to 
validate the caspase hypothesis. 
 
II) In order to identify the BRCT domain in nuclear and mitochondrial samples. 
Firstly, we suggest the production of recombinant PARP-B with aim to obtain 
polyclonal antibodies which will be used in protein immunoprecipitation in 
nuclear and mitochondrial fractions. 
In long term: 
 
I. Analysis of mitochondrial Poly(ADP-ribose)tion in mutants of BER 
mechanism for key steps. Also using siRNA of mitofilin orthologs  it would be 
possible to validate the role of mitofilin in PARP-B localization.  
II. Therapeutic application against cancer. The production of recombinant protein 
MTS-p24 (that represents PARP-B DNA blinding domain with mitochondrial 
target). Besides to culture the stable line S2 cells transfected with protein 
MTS-p24, analysis of S2 sensibility to oxidative stress or irradiation. This 
model can show various responses with possible application in human cells 
(WT and prostatic cells cancerous).  
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Annexe 1: pGEM7z(+) vector 
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 Annexes 2 :  pMT puro vector 
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Annexe 3: pBAD24 vector  
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Annexe 4: Relative positions of primers in the plasmids J2, C4 and A8. Amplification product sizes.  
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Annexe 5: PCR amplifications of plasmids C4, J2, A8 and the vectors pMT puro and pBAD24 using specific 
primers (annexe 4).  
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Annexe 6 : Relative positions of KpnI, XhoI and PmeI in the plasmids J2, C4 and A8.  
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Annexe 7: DNA sequence (3718 pb) of parpB-GFP from the C4 plasmid. The ATG (start codon) was represented 
in green and TGA (stop codon) in red colors. The ccc in violet color represents SmaI remaining site following 
digest and the tag GFP was illustrated in blue color. 
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Annexe 8: DNA sequence (3116 pb) of parpB-V5 from the J2 plasmid. The ATG (start codon) was 
represented in green and TGA (stop codon) in red colors. The ccc in violet color represents SmaI 
remaining site following digest and the tag V5 was illustrated in blue color. 
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Annexe 9: DNA sequence (3068 pb) of parpB-V5-(Hist)6 from the A8 plasmid. The ATG (start codon) 
was represented in green and TGA (stop codon) in red colors. The ccc in violet color represents the 
SmaI remaining site following digest and the targ V5 was illustrated in blue color and histidine tag was 
represented in brown color. 
                                                     
 
